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INTRODUCTION 
 
Diabetes mellitus is a chronic disease with chronic microvascular and macrovascular 
complications.  India is considered by many, as the diabetic capital of the world.  Like in 
other developing countries, complications of diabetic foot such as ulceration and infections, 
apart from causing high morbidity and mortality, also have social, and economic 
ramifications (Ako et al., 2006
10
; Shankar et al., 2005
11
; Gadepalle et al., 2006
12
).  It has been 
reported that as high as 15 % of all diabetics are prone to develop ulcers in their feet during 
their life time. These can result in severe tissue destruction and can lead to some form of 
amputation (Lipsky et al., 2004
13
).  The major concern at present is the increasing incidence 
of multi-drug resistant organisms.  The problem of multi-drug resistant organisms were 
poorly studied because of lack of uniform definitions and specific criteria to name an 
organism as multi-drug resistant.  The European center for disease control and prevention has 
defined criteriae, which are applicable universally.  Very few studies have been done in India 
to analyse the prevalence and risk factors of multi-drug resistant organisms in relation to 
diabetic foot ulcers.  The impact caused by multi-drug resistant organism were least analysed 
in Indian litearature.  Hence this study was done to analyse the prevalene, riskfactors and 
impact of multi-drug resistant organisms in diabetic foot ulcers at a tertiary care hospital. 
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ABSTRACT 
 
Aim: 
To study the prevalence, risk factors and impact of multi-drug resistant organism (MDRO) 
infection in diabetic foot ulcers. 
 
Methodology: 
150 diabetic patients with foot ulcer were prospectively studied.  Detailed clinical history and 
clinical examination of the ulcer were done for all patients.  Patients were screened for 
neuropathy, nephropathy, retinopathy, peripheral arterial disease and underlying 
osteomyelitis using appropriate methods.  The microbiological profile was analyzed in detail 
for each patient.  Using internationally accepted criteria, the multidrug resistant organisms 
were identified.   
Infected ulcers were grouped into those with MDRO and those without MDRO and were then 
compared using univariate analysis. In order to identify the risk factor, for the presence of 
MDRO, analysis by logistic regression was done.  Each patient was followed for a period of 
ten weeks to assess the status of wound healing.  The impact of MDRO was assessed by 
analyzing the associations of amputations, duration of hospital stay, status of wound at ten 
weeks with MDRO infected ulcers using appropriate statistical tools.  The influence of other 
factors on wound healing were analyzed by the same statistical tools. 
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Results : 
MDRO were isolated from 99 patients of 150 ( 66 % ).  54.8 % (153 out of 279) of isolated 
organisms were multidrug resistant organisms.  The commonest organism isolated  in our 
study was Escherechia coli followed by Staphylococcus aureus and Pseudomonas aeruginosa. 
By univariate analysis poor glycaemic control, previous hospitalisation, previous history of 
amputation, previous antibiotic usage, size of ulcer, necrotic ulcer, recurrent ulcers, higher 
grade of ulcer, presence of osteomyelitis, presence of retinopathy, peripheral vascular 
disease, neuropathy and polymicrobial culture, were associated with significance in those 
with MDRO infected foot ulcers.   
Analysis by Logistic regression indicated that, only two factors significantly increased the 
risk of acquiring MDRO infection; 1) recurrent ulcer (OR = 3.39, p < 0.05, 95 % CI = [ 1.081 
– 10.664 ] ),  2) Higher grade of ulcer ( OR = 13.44, p < 0.001, 95 % CI = [3.595 – 50.278] ).  
It was found that the mean duration of hospital stay of patients with MDRO infections was 
15.36 days (p < 0.001 ).  MDRO in the foot ulcers significantly increased the frequency of 
amputations (p < 0.01).   
MDRO infected ulcers had no impact on wound healing although they were significant by 
univariate analysis.  By Logistic regression, age ( OR = 0.942, p <0.1, 95 % CI = [ 0.882 – 
1.005 ]), presence of  PVD ( OR = 7.872, p < 0.01, 95 % CI = [2.009 – 30.849 ] ), 
osteomyelitis ( OR = 8.280, p<0.01, 95 % CI = [ 1.768 – 38.766 ]),  nephropathy ( OR = 
4.36, p < 0.05, 95 % CI = [ 1.226 – 15.564 ]), inter-digital / digital ulcer ( OR = 0.073, p < 
0.05 , 95 % CI = [ 0.006 – 0.869 ]), elevated HbA1c ( OR = 6.020, p < 0.05, 95 % CI = [ 
1.240 – 29.226 ]), and higher Grade of ulcer ( OR = 4.10, p <0.1, 95 % CI = [ 0.863 – 
19.549]) significantly delayed wound healing. 
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Conclusion : 
The prevalence of MDRO is alarmingly high in infected diabetic foot ulcers.  Recurrent 
ulcers and higher grade of ulcers are more prone to acquire MDROs.  MDROs in diabetic 
foot ulcers are associated with longer duration of hospital stay and higher rates of 
amputations.  MDROs have no significant impact on wound healing.  Presence peripheral 
arterial disease, osteomyelitis, nephropathy, inter-digital / digital ulcers,  higher grade of ulcer 
and poor glycaemic control delays the healing of foot ulcer. 
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REVIEW OF LITERATURE 
 
Diabetes – as old as history 
Diabetes is indeed one of the oldest maladies in the history of mankind.  Symptoms and 
suggested treatment have been mentioned in the Ebers Papyrus of 1500 B.C.  Even during 
biblical times, gangrene of the foot has been mentioned.  In Chronicles II, possibly the first 
case of gangrene of the foot, and in all likelihood due to diabetes, was described.  Pryce, a 
British surgeon, more than a century ago had described the relationship between diabetic 
neuropathy, the insensitive foot, and foot ulceration
1
. 
 
Global burden of diabetes mellitus : 
Diabetes, as per the current statistics, is known to affect in excess of 190 million people 
worldwide. This is likely to reach more than a quarter of a billion by 2025. Most of these 
could be in the developing countries. India has been considered by many as the “Diabetic 
capital of the world”.  In India alone there are over 35 million people suffering from 
daibetes
2
.  This would more than double and be nearly 75 million by 2025, possibly as a 
consequence of increased life expectancy, lifestyle with lack of exercise and changing dietary 
patterns
3
.  Insulin now being available easily, and also with therapy of diabetes being more 
sophisticated, patients live longer to develop the late microvascular complication of diabetes 
like retinopathy, nephropathy, neuropathy and peripheral vascular diseases
.4 
.  Thus the 
treatment of the morbidity of diabetes poses a stiff challenge to the clinicians. 
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Chronic leg ulcers : 
Chronic leg and foot ulcers resulting in non-healing wounds, occur because there is a 
disruption in the underlying physiology of the leg. This disruption has been frequently 
associated with venous, arterial or metabolic factors
5
.  Undoubtedly these lesions lead to 
significant morbidity.  Studies conducted in the UK have shown that, foot ulcers are 
approximately 1.48/1000 population 
6
. There is also overwhelming evidence that this 
prevalence increases as the age advances 
6 – 8
.  In those patients over 65 years, this has been 
as high as 36/1000 population 
9
. 
 
Diabetic foot syndrome 
Diabetic foot syndrome is trinity of ulcer, infection and destruction of deep tissues of 
foot.  Diabetic foot ulcer is one of the most common complications of diabetes, yet it is often 
ignored by the patients.  Complications of diabetic foot such as ulceration and infections, 
apart from causing high morbidity and mortality, also have social, and economic 
ramifications
10-12
.  15% of all patients with diabetes have a probability of developing a foot 
ulcer during some stage in their lives.  These ulcers are highly prone to develop infections 
and rapidly spread, causing significant tissue destruction leading on to some form of 
amputation 
4,13
.  
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Diabetic foot ulcers and amputations 
There are in excess of one million amputations being done annually worldwide, with as many 
as 70% of them being a direct consequence of diabetes.  Apart from the devastating effect of 
amputation on people’s lives, there is also the financial burden, as foot problems being one of 
the commonest causes for hospitalization in people afflicted with diabtes
66
.   In developing 
countries such as India, already with stretched health care infrastructure and resources, it has 
been found that this problem of diabetic foot consumes as much as 40 % of it.  Patients with 
diabetes have a 17 times more chance of developing a gangrene of the foot, and gangrene of 
the lower limbs occurs in about 30% of patients with type II diabetes 
14
.   There is a 6.5% 
chance of a major amputation in patients with diabetes, which is 5 to 6 times that of a non 
diabetic patient. It has been found that teen ager diagnosed to have diabetes, has a very high 
probability of needing a major amputation by the time he reaches the sixth decade.  It has also 
been seen that 30% to 40% of the patients with diabetes, who have had an amputation will 
need another  amputation in the opposite limb within 3 years
15
. 
The mortality after one year following lower limb amputation is in the range of 11%-41%.   
This increases to 20%- 50% at the end of 3 years and 39%-68% at the end of 5 years
16
.  St 
Vincent Declaration, which emerged at a meeting held under the aegis of WHO, in 1989, set 
a target of 50% reduction of lower limb amputations in 5 years, as a prime target in diabetes 
affected patients.  More than 2 decades later, the target is still to be met
17
, as evidenced by the 
fact that a lower limb is lost consequent to diabetes every half a minute
18
. 
 
 
 
 
P a g e  | 8 
 
Pathology of diabetic foot ulcers 
A combination of neuropathy, ischemia and infection occurs, leading to an unenviable 
situation that poses a challenge to the health system.  It can be said, treatment of diabetic foot 
ulcer has been improved considerably.  However 1/3 to ½ of these patients may not respond 
to therapy
19
.  There has also been significant progress in the form of re-vascularization 
procedures
20
.  But these procedures are very skill intensive and are not accessible 
everywhere
18
. Newer imaging techniques like MRI, MRA 
21
, and introduction of new higher 
antibiotics, are now providing some hope
13
. However, there is the threat of infections with 
MRSA (methicillin-resistant staphylococcus aureus) and ESBL (extended spectrum beta 
lactamase) producing organisms.
22
. 
 
Diabetic foot infections : Basics 
In the United States, about a quarter of all patients with diabetes are likely to develop foot 
ulcerations at some point, and a majority of these run the risk of becoming infected
33
.  The 
association of bacteria with ulcer can be classified into four types : contamination, 
colonization, critical colonization and infection. Contamination and colonization are milder 
forms of microbial invasion and do not cause a detrimental effect in the process of healing. 
When this begins to adversely affect the process of wound healing, the term ‘critical 
colonization’ is used 23.  The Consensus Development Conference on Diabetic Foot Wound 
Care 
24
 agreed that an ulcer should be deemed infected when there are purulent secretions or 
the presence of two or more signs of inﬂammation (erythema, warmth, tenderness, heat, 
induration).  All chronic wounds, however by their very nature of chronicity, may not always 
show these above mentioned classic features of infection. It has been therefore suggested that 
the list should be expanded and should include signs speciﬁc to secondary wounds (serous 
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exudate associated with concurrent inﬂammation, delayed healing, discoloration of 
granulation tissue, friable granulation tissue, foul odour and wound breakdown)
25
. 
Microbiologically, the indicators of infection proposed are a critical bacterial load, an 
interplay between multiple bacterial species infecting simultaneously, and the presence of 
specific pathogens.  It can be said that that the mere presence of bacteria does not indicate 
wound infection.  It is now known that there is a direct effect of critical microbial load on the 
healing outcome of both acute and chronic wounds
26
.  There is definite evidence that wounds 
do not heal when there is a bacterial load in excess of 10
5
 bacteria per gram of tissue
27
. 
Microorganisms have been identiﬁed in the deeper layers of all chronic wounds.  However, 
their role and the effect of specific species of bacteria on wound healing are yet to be 
elucidated.  All chronic wounds are colonized.  Microbial study can be useful only when 
considered in conjunction with clinical features, to identify the bacteriae causing infection 
and their antibiotic sensitivities 
28,29 
.
 
  This should lead to an improved antibiotic regimen
28
. 
 
Diabetic foot infections – Treatment challenges : 
Highlighting the difﬁculties for the clinician, the International Working Group on the 
Diabetic Foot recommended a complex antibiotic strategy which involves intravenous and/or 
possibly oral use of empirical broad-spectrum antibiotics in the presence of deep foot 
infections
30
.  The recommendations include ampicillin/sulbactam, ticarcillin/clavulanate, co-
amoxiclav, clindamycin and a quinolone, second or third generation cephalosporin and a 
quinolone, and metronidazole with a quinolone 
30
.  It has been recommended that only ulcers 
with extensive cellulitis and/or osteomyelitis should be treated with intensive, systemic 
antibiotics
31
. When wounds are infected with more than one bacteria, it would be necessary to 
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use a broad spectrum antibiotic, but there is as yet no final word on which antibiotic to use as 
there is inadequate evidence to show that one is better than the other
31
.  Proper management 
of these infections requires appropriate antibiotic selection based on culture and antibiotic 
susceptibility results 
32
. 
 
Bacteriology of diabetic foot infections : 
 Wounds are treated initially with an empirical antibiotic. Treatment with a specific antibiotic 
based on antibiotic sensitivity test, should be instituted to improve the healing.  Many studies 
have reported varied and contradictory results. Literature review has shown that 
Staphylococcus aureus is the main etiological pathogen 
22,34,35
.  Two recent studies reported  
gram-negative aerobes being the predominant pathogens 
11,12
.  Etiological pathogens have 
varied over time and geographical location 
 11, 12, 36
.   It is interesting to note, when specimens 
are collected properly, transported promptly and validated culture techniques are used, 
polymicrobial isolates are usually obtained from diabetic foot infections
5, 37, 38, 39, 40, 41, 42
. 
Furthermore, some studies have shown that when the wounds have polymicrobial infections 
there is a synergism of these organisms, as a result of which, virulence factors, such as 
hemolysins, proteases, and collagenases are produced. These are detrimental to wound 
healing and result in infections becoming chronic 
43, 44, 45, 46
.  There is also a formation of a 
biofilm, which thwarts the entry of antibiotics into the infected site 
47
.   It can therefore be 
said that polymicrobial infections can have challenging clinical ramifications
 38,43
. 
Recent studies using molecular techniques have emphasized the complex ecology of these 
wounds 
48,49
. The average number of bacterial species per ulcer has been found to be in the 
range of  1.6 up to 4.4 
50 – 53
. Another interesting point to note that even when ulcers do not 
show any clinical sign of infection, more than one bacterial species has been isolated 
54
. 
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In a Malaysian study, 287 bacteriae were isolated from 194 patients. This showed an average 
of 1.47 isolates per patient. Gram negative bacteria ( 52 % ) were most frequently isolated. 
Among these gram negative bacteria, proteus spp. (28%), pseudomonas aeruginosa (25%), 
klebsiellapneumoniae (15%) and Escherichia coli (9%) were isolated commonly.  Among the 
Gram-positive bacteria most common organism isolated was Staphylococcus aureus ( 44 % 
),followed by Group B streptococci (25%) and Enterococcus spp (9%).  The antibiogram of 
these isolates showed that the gram negative bacteria were sensitive to imipenem and 
amikacin and the gram positive bacteria were sensitive to vancomycin.
64
. 
 
A Chennai study showed aerobic pathogens were isolated in 66.8% patients and anaerobic 
pathogens were isolated in 33.2%.  There was a greater isolation of anaerobic pathogens with 
higher Wagner’s grade ulcers.  These ulcers which were infected with anaerobic pathogens, 
took longer to heal.  Neuropathy was common in patients infected with both aerobic and 
anaerobic pathogens. The two groups showed no significant difference in associated 
peripheral vascular disease.  Among the aerobic pathogens isolated, enterobacteriaceae (48%) 
was the commonest. Staphylococcus spp (18.2%), streptococcus spp (16.8%) and 
pseudomonas spp (17%) were the other aerobic isolates seen frequently.  Anaerobes isolated 
were peptostreptococcus spp and clostridium spp (69.4%).  Further, gram-negative anaerobes 
like bacteroides spp and fusobacterium spp were present in 30.6%.  Strict aerobic pathogen 
and strict anaerobic pathogen infected ulcers had a longer healing time
65
. 
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Multi drug resistant organisms( MDRO ) and diabetic foot ulcers : 
Many different definitions for multidrug-resistant (MDR) bacteria have emerged in the 
literature to outline the different patterns of resistance seen.  European Centre for Disease 
Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC), 
created standardized international criteria, using which multi-drug resistance profiles could 
be identified in Staphylococcus aureus, Enterococcus spp, Enterobacteriaceae(other than 
Salmonella and Shigella),Pseudomonas aeruginosa, and Acinetobacter spp. All these bacteria 
have often let to multidrug resistance 
67
.  
Clinicians are often challenged by the lethal combination of increasing numbers of patients 
with chronic wounds and with the rising problem of multi antibiotic resistance. The 
polymicrobial infection  of chronic wounds provides an ideal ambience for exchange of 
genetic material between bacteria.   
In the United States, the ﬁrst two cases of vancomycin resistant Staphylococcus aureus were 
both isolated from patients with chronic wounds 
55,56
.  A study found more than 50 % of  
Staphylococcus aureus isolates from patients admitted to dermatology wards with leg ulcers 
to be Methicillin Resistant Staphylococcus Aureus ( MRSA ).  Further more than one-third of 
Pseudomonas aeruginosa isolates were found  to be resistant to ciproﬂoxacin57.  Another 
study found 40% of Staphylococcus aureus isolated from non-limb-threatening infected foot 
ulcers to be MRSA; giving MRSA a prevalence of 15% in all diabetic patients with infected 
ulcers
50
. 
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There were signiﬁcantly increased  MRSA isolates from patients who had received previous 
antibiotic therapy.  A follow-up study, identiﬁed a similar proportion of methicillin resistance 
in the Staphylococcus aureus isolates, but showed that it had almost doubled to 30 % over a 3 
year period 
22
.   
Microbial isolates from infected diabetic foot ulcers, who had received no prior antibiotics 
during the previous two weeks, found 12% of Staphylococcus aureus, 46% of Staphylococcus 
epidermidis and 45% of Staphylococcus haemolyticus to be methicillin resistant
58
.  High 
resistance was found to erythromycin in most species of gram-positive organisms.  An audit 
of chronic wounds found 12.5% of Staphylococcus aureus isolates and 21.7% of 
Pseudomonas species isolates to be resistant to a clinically relevant antibiotic
59
. 
Literature has found MRSA in as many as 15–30% of diabetic wounds 4,11,32,50. Suggested 
risk factors for MRSA include cross-contamination of wounds from the patients themselves, 
fomites or health care professionals, prolonged use of antibiotics, previous hospitalization 
and illness severity
61,63
.  Infection with multidrug-resistant organisms (MDROs) may increase 
the morbidity and mortality, the duration of hospital stay and the cost of treatment
60
. High 
prevalence of antibiotic resistance, like MRSA, suggests that empirical antibiotics may not 
cover these resistant organisms 
62
. 
Ulcers infected with MRSA take twice as much time to heal 
50
.  There is as yet no consensus 
on the relevance of MRSA colonization in clinically non-infected ulcers, though it has been 
seen it may take upto six months to disappear 
22
. 
A study from New Delhi had found that on an average 2.3 species were isolated from each 
ulcer. The majority (65.0%) were infected with aerobes only.  Staphylococcus aureus was the 
most frequent pathogen, found in nearly 14% of infections.  Staphylococcus aureus showed a 
high frequency (56.0%) of resistance to the antibiotics tested.  ESBL production was seen in 
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44.7% of gram-negative bacilli, Proteus species showing the highest production followed by 
Escherichi coli.  MDRO were isolated from more than two-thirds of the ulcer.  Patients with 
non MDROs had a higher frequency of hypertension, and this was the only factor 
significantly associated with it.  Both MDROs and Non MDROs had a similar duration of 
hospital stay, and showed no significant differences in the demographic pattern.  An ulcer of 
size of >4 cm
2
 was more likely to be infected with MDROs.  Patients with MDRO ulcers had 
neuropathy and osteomyelitis more frequently. MDROs had a higher association with 
peripheral vascular disease, association however, had only a borderline significance.  
Significantly, surgical treatment was required more in patients with MDRO infections. 
Multiple logistic regressions showed a high degree of association between presence of 
neuropathy and ulcer size > 4 cm
2 12
.  
In a study done at Aligarh, India, gram negative aerobes were most frequently isolated 
(63.8%), followed by gram positive aerobes (36.1%).  Anaerobes were isolated in 31.4%.  
45% of patients showed MDROs.  ESBL production and methicillin resistance were noted in 
68.5% and 43.2% of bacterial isolates respectively.  MDRO positive status was associated 
with the presence of neuropathy, osteomyelitis, and ulcer size >4 cm
2.
but not with patients 
characteristics like age, sex, ulcer type and type of diabetes, or duration of hospital stay 
64
. 
In a study done at France by Hartemann-haurier et al
60
, 18% of admission specimens were 
positive for MDRO.  There was no association of MDRO-positive status with the patient 
profile (age, sex, type of diabetes, complications of diabetes), duration of wound, or  type of 
wound (neuropathic or ischaemic). Multivariate analysis showed that, the only two factors  
associated significantly with positive MDRO status were, a history of prior hospitalization for 
the same ulcer and the presence of osteomyelitis. MDRO-positive status either on admission 
or during follow-up had no association with time to healing. 
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The study from UK, has found that Staphylococcus aureus being the commonest isolate.  
30.2% of patients with foot ulcers harboured MRSA.  They also found that there was no 
increase in hospitalisation as a consequence of MRSA and it is not related to previous 
antibiotic usage.
22
 
The increasing antimicrobial resistance is a conundrum to clinicians and microbiologists 
alike. In India however there is a lack of literature on the frequency of MDRO infections and 
the consequences of such infections in patients with diabetic foot ulcers. 
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METHODOLOGY 
 
This study is a prospective observational study conducted to find the prevalence, risk factors 
and the impact of multidrug resistant organisms in diabetic foot ulcers.  It was conducted 
during the months January 2011 to July 2012 at PSG Institute of Medical Sciences & 
Research, Coimbatore.  
150 diabetic patients with foot lesions were included in the study.  Written informed consents 
were obtained from the patients.  Detailed clinical history of the patient and other relevant 
data were collected using structured case report forms.   
Mode of presentation of foot ulcers were classified as grade I – V as per Meggit Wagner 
Classification System (Wagner,1981).  Ulcers were categorised into necrotic / non necrotic 
ulcers based on signs of infection (swelling, exudates, surrounding cellulitis, odour, tissue 
necrosis and crepitation).  Size was determined by multiplying the longest and widest 
diameters expressed in centimeters squared (cm2), and the diagnosis of extension to the bone 
was made by plain radiographs.  
Presence of neuropathy was detected by assessing vibration sensation using a 128 HTZ 
tuning fork and a 10g Semmes - Weinstein monofilament.  Peripheral diabetic neuropathy 
was defined as an abnormal monofilament test, as described by the international consensus on 
the diabetic foot
102 .  Presence of nephropathy was detected by screening the patient’s urine 
for micro / macro-albuminuria after ruling out urinary tract infection.   
 
P a g e  | 17 
 
The fundus was examined by the ophthalmologist for evidence of retinopathy.  Absence of 
both dorsalis-pedis pulsations and / or an Ankle Brachial Index (ABI) less than 0.9 was 
termed as peripheral vascular disease
101
.  
Wound swabs were obtained from the floor of the ulcer, before starting on empirical 
antibiotic therapy.  Direct microscopic examination and aerobic cultures were done by 
standard methods.  The bacteriological spectrum and the sensitive antibiotics were noted for 
each patient.   
All patients were started on empirical antibiotics depending on the status of the wound.  In 
mild infection amoxyclav (amoxicillin/clavulanic acid) was given by oral route. But in 
patients with necrotic wounds, an additional antibiotic, clindamycin or metronidazole, was 
added for gram negative coverage and the intravenous route was preferred.   
In the presence of an unhealthy ulcer, surgical debridement / amputation was done 
immediately after admission.  Later wounds were managed with regular dressings and 
antibiotics modified according to the culture report. All patients were re-inspected or 
enquired over phone after a period of 10 weeks to assess the status of wound. 
For each patient the following details were entered: age, sex, duration of ulcer, duration of 
diabetes, glycaemic control,  presence of retinopathy, presence of micro/macro-albuminuria, 
hypertension, history of smoking, history of previous amputation, duration of hospital stay, 
interventions (medical and surgical), organisms cultured from ulcer, antibiotic profile and 
status of ulcer after 10 weeks. 
Previous hospitalization was defined as any hospital stay, which was not necessarily for the 
management of ulcer, during the year preceding the current hospitalization. Previous 
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antibiotic usage was defined in our study, as those who had received antibiotics in six months 
preceding current hospitalization. 
The data was collected and entered in the SPSS data sheet.The data was analyzed using SPSS 
20 for descriptive statistics.  To assess the risk factors for acquiring MDRO, the patients were 
grouped into MDRO and non-MDRO groups.  All patients who had at least one multidrug 
resistant organism were grouped under MDRO group.   
The test variables were compared using Chi-square test for qualitative variables and Student’s 
test for quantitative variables.  The variables for which the association was statistically 
significant ( p< 0.1 ) were introduced in a logistic model to explain the presence of MDRO.  
The impact of multi-drug resistant organisms was assessed by analyzing the mean duration of 
hospital stay and its association with amputations, using the above said statistical tools.   
For analyzing the factors influencing the wound healing, the patients were grouped into two 
groups: healed and non-healed group.  At 10 weeks time, the completely healed ulcers or 
those which had reduced in size were deemed to have healed.  The rest, including those with 
ulcers, whose size remained the same were grouped as non-healed group.  Influence of 
various factors were analyzed using same statistical tools. 
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Methodology 
Aim  To study the prevalence of multi-drug resistant 
organism infection in diabetic foot ulcers. 
 To analyze the risk-factors contributing to infection 
with multidrug resistant organisms. 
 To assess the impact of MDRO infection on ulcer 
healing. 
 To analyze other factors influencing wound healing 
Study design: A Prospective Hospital based Observational study   
Study Population: All diabetic patients (both IP & OP) with foot lesions over 
a period  (Jan 2011 – July 2012 ) were included in the 
study. 
Sample Size: 150 
Inclusion Criteria All diabetic patients with foot lesions 
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Methodology 
Exclusion Criteria:  Diabetic patients with pure venous ulcers  
 Those patients with neurological disorders and other 
known causes of neuropathy, other  than diabetes related 
neurological dysfunction will be excluded from the 
study 
 Those who do not consent 
Duration of the study 18 months 
Study Period January 2011 - July 2012 
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CLINICAL PROFORMA 
 
 
Name :                                                   Age :                                Sex :  
 
IP No :                                                   OP No : 
 
DOA :                                       DOD :                             Duration of Stay :           days 
 
Occupation :                                        Per-Capita Income : 
 
Mobile Number : 
 
 
Diabetic Status : 
 
Type of diabetes :             Type I [  ] 
                                         Type II [  ] 
 
Duration -                yrs,        Newly Detected [  ] 
 
Latest HbA1C :                           % 
 
Smoking History :             Yes [  ]  
No  [  ] 
 
 
 
Alcoholism :                    Yes [  ]  
                                          No [  ] 
 
Nature of work :                  Manual [  ]  
                                         Sedentary [  ] 
 
Other concomitant Illness :                HT [  ]  
                                            Nephropathy [  ]  
                                             Retinopathy [  ] 
 
 
Past history of amputations for foot problems : Yes [ ]  
                                                                             No [ ] 
 
 
Previous hospitalization for the same complain : Yes [  ] 
                                                                                No [  ] 
 
                   How many years back ---- 
                   Reason for hospitalization ---- 
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Previous antiobiotic usage :            Yes [  ] 
 
                                                         No [  ] 
 
Recurrent ulcer                  :             Yes [  ] 
 
                                                          No [  ] 
 
Local examination of the foot lesion:  
 
Ulcer : 
 
                                         Size – 
                                         Depth –  
 
Duration of ulcer : 
 
Osteomyelitis :          present / Absent 
 
Nature            :        Necrotic / Non-necrotic 
 
Site                 : 
 
 
 
 
Wagner’s Grade  : 
 
 
 Evidence of peripheral vascular disease : 
 
 Dorsalispedis Artery Palpable : Yes [  ]        No [  ]         Impaired [  ] 
 
Posterior tibial Artery palpable : Yes [  ]       No [  ]         Impaired [  ] 
 
     Ankle brachial index _______________________ 
 
 
Assessment  of  sensorimotor Neuropathy : Monofilament test : present [  ] 
 
                                                                                                       Absent [  ] 
 
 
Culture               :  Monomicrobial [  ] 
 
                               Polymicrobial [   ] 
 
Organisms          : 
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MDRO               :  Present [  ] 
 
                              Absent [  ] 
 
 
 
Antibiotics used : 
 
Treatment during the hospital stay           : 
 
Duration of hospital stay                          : 
 
 
Follow up : 
 
At ten weeks                                            :  
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RESULTS 
 
150 diabetic in-patients with foot ulcers were included in the study, after obtaining their 
consent.  78% of the patients were 51 years or older, with the average age being 58.21.  
74.6% of the patients were males, showing a distinct male preponderance.  Most of the 
patients (44%) belonged to class II socio-economic status followed by class III (26 %), as per 
Modified Prasad’s Classification(103).  No patients were in class V socio-economic status. 
(Table 1) 
 
Table 1: Demographic details 
Variable Number Percentage 
 
AGE DISTRIBUTION 
< 40 
41 – 50  
51 – 60  
61 – 70 
71 – 80  
81 – 90 
 
 
 
                     5 
                    16 
                    55 
                    62 
                    10 
                     2 
 
 
3.3 % 
10.7 % 
36.7 % 
41.3 % 
6.7 % 
1.3 % 
 
SEX DISTRIBUTION 
MALE 
FEMALE 
 
 
 
   112 
   38 
 
 
74.6 % 
25.33 % 
 
SOCIO-ECONOMIC 
STATUS 
Class I 
Class II 
Class III 
Class IV 
Class V 
 
 
 
   39 
                 66 
                 39 
   6 
                 0 
 
 
26 % 
44 % 
26 % 
4 % 
0 % 
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Almost all the patients had Type II diabetes, with only 4% of them having Type I.  Only 
19.33% of patients had a good glycemic control, with HbA1c 6 – 7 %. 40 % of patients with 
ulcer had diabetes for less than 5 yrs.  (Table 2) 
 
Table 2: Diabetes profile 
Variable Number Percentage 
 
DURATION OF DIABETES 
< 5 YRS 
5-10 YRS 
10-15 YRS 
15 – 20 YRS 
>20 YRS 
 
 
 
60 
51 
26 
11 
2 
 
 
40 % 
34 % 
17 % 
7.3 % 
1.3 % 
 
GLYCEMIC CONTROL 
6-7 % ( Good ) 
7-8 % ( Fair ) 
>8 % ( Poor )  
 
 
 
29 
54 
67 
 
 
19.33 % 
36 % 
44.66 % 
 
 
68 % of patients had ulcers of less than one month duration.  Less than 10% of the ulcers 
studied had a duration of 2 months or greater.  With respect to the size of the ulcer, most were 
between 4 to 8 cm
2
 and 8 to 16 cm
2
.  A majority had superficial ulcers.  Most of the patients 
had Wagner’s grade II, III, or IV ulcers.  It was interesting to note that there were very few 
ulcers with Wagner’s grade V.   There was almost an equal distribution of necrotic and non-
necrotic ulcers.  Similarly recurrent and non-recurrent ulcers also had an almost equal 
distribution. 34% of ulcers had associated osteomyletis.  As far as the site of the ulcer was 
concerned, 28% were seen in the heel, followed by digits / inter digital areas (21.33 %).  
(Table 3) 
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Table 3: Foot ulcer profile 
Variable Number Percentage 
 
DURATION OF ULCER 
<1 Month 
1-2 Months 
2-3 Months 
>3 Months 
 
 
                    102 
                     34 
                      9 
                      5 
 
 
68 % 
22.7 % 
6 % 
3.3 % 
 
 
SIZE OF THE ULCER 
<4 cm
2
 
4-8 cm
2
 
8-16 cm
2
 
16-24 cm
2
 
>24 cm
2 
 
 
 
                    11 
                    49 
                    61 
                    23 
                     6 
 
 
7.3 % 
32.7 % 
40.7 % 
15.3 % 
4 % 
 
 
DEPTH OF ULCER 
Superficial 
Deep 
 
 
 
       92 
       58 
 
 
61.33 % 
38.66 % 
 
GRADE OF ULCER 
Grade I 
Grade II 
Grade III 
Grade  IV 
Grade V  
 
 
 
      17 
      40 
      45 
     35 
     13 
 
 
11.33 % 
26.66 % 
30 % 
23.33 % 
8.66 % 
 
NATURE OF ULCER 
Non-necrotic 
Necrotic 
 
 
 
    78 
    72 
 
 
52 % 
48 % 
 
RECURRENCE 
Non-recurrent 
Recurrent 
 
 
 
   79 
   71 
 
 
52.66 % 
47.33 % 
 
OSTEOMYELITIS  
Absent 
Present 
 
 
 
   99 
   51  
 
 
66 % 
34 % 
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Variable Number Percentage 
 
SITE OF ULCER 
Plantar 
Margins 
Heel 
Digits 
Malleoli 
Leg 
Multiple areas 
 
 
 
16 
24 
42 
32 
18 
16 
2 
 
 
10.66 % 
16 % 
28 % 
21.33 % 
12 % 
10.66 % 
1.33 % 
 
 
 
 
 
 
 
 
I 
11% 
II 
27% 
III 
30% 
IV 
23% 
V 
9% 
Distribution of ulcers as per Wagner's 
grading system 
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Plantar 
11% 
Margins 
16% 
Heel 
28% 
Digits 
21% 
Malleoli 
12% 
Leg 
11% 
Multiple 
1% 
Distribution of sites of ulcer 
Present 
34% 
Absent 
66% 
Prevalence of osteomyelitis 
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Wagner’s Grade 1 Ulcer 
Superficial Diabetic ulcer 
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Wagner’s Grade 2 Ulcer 
Ulcer involving Ligament, Tendon or 
Fascia without abscess/osteomyelitis 
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Wagner’s Grade 3 Ulcer 
Deep ulcer with abscess/osteomyelitis 
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Wagner’s Grade 4 Ulcer 
Gangrene of a part of Foot 
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Wagner’s Grade 5 Ulcer 
Extensive Gangrene of the Foot 
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Peripheral arterial disease was seen in 52.66 %, retinopathy detected in 24.66 % and 
albuminuria suggesting nephropathy was found in 48.66 %.  Majority of the patients had 
neuropathy.  61.33 % were hypertensive.  50% of the patients were smokers and 41.33 % 
alcoholics.  History of previous hospital admission in the last one year was seen in 53.33 %.  
21.33 % of patients had history of some form of amputation.  42.66 % of the patients had a 
history of antibiotic use in the preceding 6 months before admission.  (Table 4). 
 
Table 4: Other associated history 
Variable Number Percentage 
 
ARTERIOPATHY 
Absent 
Present 
 
 
 
                     79 
                     71 
 
 
52.66 % 
47.33 % 
 
RETINOPATHY 
Absent 
Present 
 
 
 
    113 
                    37 
 
 
75.33 % 
24.66 % 
 
NEPHROPATHY 
Absent 
Present 
 
 
 
                    77  
    73 
 
 
51.33 % 
48.66 % 
 
NEUROPATHY 
Absent 
Present 
 
 
 
                   34 
                  116 
 
 
22.66 % 
77.33 % 
 
HYPERTENSION 
Absent 
Present 
 
 
 
                   58 
                   92 
 
 
38.66 % 
61.33 % 
 
SMOKING 
Non smoker 
Smoker 
 
 
 
                   75 
                   75 
 
 
50 % 
50 % 
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Variable Number Percentage 
 
ALCOHOL 
Non alcoholic 
Alcoholic 
 
 
 
                     88  
                     62 
 
 
58.66 % 
41.33 % 
 
PREVIOUS 
HOSPITALIZATION 
Not hospitalized 
Hospitalized 
 
 
 
                     70 
                     80 
 
 
46.66 % 
53.33 % 
 
H/O AMPUTATION 
Absent 
Present 
 
 
 
    118 
    32 
 
 
   78.6 % 
                   21.33 % 
 
PREVIOUS ANTIBIOTIC 
USE 
Absent 
Present 
 
 
 
                    86 
                    64 
 
 
57.33 % 
42.66 % 
 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
Retinopathy Arteriopathy Nephropathy Neuropathy
24.66% 
47.33% 48.66% 
77.33% 
Prevalence of microvascular complications  
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42 % of patients required wound debridement and more than a third of the patients underwent 
some form of amputation.  32 of the 150 patients (21,3%) had only conservative treatment. 
All patients were followed up at 10 weeks,  40 % of the patients had ulcers either healed or 
reduced in size.  The rest had either an increase in size of the ulcers or had some form of 
amputation.  (Table 5)  
 
 
 
Table 5: Management 
Variable Number Percentage 
 
MANAGEMENT OF 
ULCER 
 
Conservative 
Wound debridement 
Minor amputation 
Major amputation 
 
 
 
 
                     32 
                     63 
     41 
                    14 
 
 
 
21.3 % 
42 % 
27.3 % 
9.3 % 
 
 
10 WEEKS FOLLOW UP 
 
Completely healed 
Ulcer reduced in size 
Size remained the same 
Ulcer  size increased 
Minor amputation 
Major  amputation  
 
 
 
 
                     15 
                     45 
                     34 
                     1 
                     41 
                     14 
 
 
 
10 % 
30 % 
22.7 % 
0.7 % 
27.3 % 
9.3 % 
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Conservative 
21% 
Wound 
debridement 
42% 
Minor amoutation 
28% 
Major amputation 
9% 
Treatment provided during the hospital stay 
Completely healed 
10% 
Ulcer reduced in 
size 
30% 
size remained the 
same 
23% 
Size increased 
1% 
Minor amputation 
27% 
major amputation 
9% 
Status after 10 weeks 
Healed 
group 
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MICROBIOLOGICAL OBSERVATIONS : 
A total of 279 organisms were isolated from 150 patients.  On an average 1.86 species were 
isolated from each patient.  58.66 % of patients (88 of the 150 patients) had polymicrobial 
culture.  Among the isolates, most were gram negative rods (69.89 %) and almost all the rest 
were gram positive cocci.  There was a solitary gram negative coccus.  Gram positive to gram 
negative ratio, among the isolates, was 1: 2.3.   
Among the isolates, Escherichia coli was the most common one constituting 17.9%, followed 
by Staphylococcus aureus 17.6 %, followed by Pseudomonas aureginosa (16,5%).   
Multidrug resistance in the organisms, was defined as per the criteria laid down by European 
centre for Disease Prevention and Control
67
.  Multidrug resistance organisms were seen in 99 
of the 150 patients.  (Tables 6 & 7) 
 
 
Table 6: Bacteriology overview 
 Number of patients 
 
Percentage 
 
CULTURE 
Mono-microbial 
Poly-microbial 
 
 
 
62 
88 
 
 
41.33 % 
58.66 % 
 
DRUG RESISTANCE 
MDRO 
NON- MDRO 
 
 
99 
51 
 
 
66 % 
34 % 
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Monomicrobial 
41% 
Polymicrobial 
59% 
Monomicrobial vs Polymicrobial 
MDRO 
66% 
Non MDRO 
34% 
Prevalence of MDRO (% of patients ) 
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Table 7: List of isolated organisms 
ORGANISMS N PERCENT OF 
ISOLATES 
 
PERCENT OF 
CASES 
 
GRAM- POSITIVE COCCI 
Enterococcus avium 
Enterococcus faecalis 
Enterococcus faecium 
Granulicatellaadiacens 
Staphylococcus aureus 
Group C Streptococci 
Group G Streptococci 
Streptococcus pyogenes 
Streptococcus viridians 
 
 
1 
19 
4 
2 
49 
1 
1 
4 
2 
 
 
0.4 % 
6.8 % 
1.4 % 
0.7 % 
17.6 % 
0.4 % 
0.4 % 
1.4 % 
0.7 % 
 
 
0.7 % 
1 2.7 % 
2.7 % 
1.3 % 
32.7 % 
0.7 % 
0.7 % 
2.7 % 
1.3 % 
 
Total 
 
83 29.8 %  
 
GRAM-NEGATIVE RODS 
Acinetobacter baumannii 
Citrobacter diversus 
Citrobacter species 
Enterobacter aerogenes 
Enterobacter cloacae 
Enterobacter species  
Escherichia coli 
Klebsiella pneumoniae 
Morganella morganii 
Proteus mirabilis  
Proteus vulgaris   
Pseudomonas aeruginosa 
Pseudomonas fluorescens 
Providencia species 
Others 
 
GRAM-NEGATIVE COCCI 
 
 
 
13 
9 
2 
8 
1 
3 
50 
24 
4 
20 
3 
46  
1 
2 
9 
 
 
1 
 
 
 
4.7 % 
3.2 % 
0.7 % 
2.9 % 
0.4 % 
1.1 % 
17.9 % 
8.6 % 
1.4 % 
7.3 % 
1.1 % 
16.5 % 
0.4 % 
0.7 % 
3.2 % 
 
 
0.4 % 
 
 
 
8.7 % 
6.0 % 
1.3 % 
5.3 % 
0.7 % 
2.0 % 
33.3 % 
16 % 
2.7 % 
13.4 % 
2.0 % 
30.7 % 
0.7 % 
1.3 % 
6.0 % 
 
 
0.7 % 
 
Total 
 
196 70.5 %  
 
GRAND  TOTAL 
 
 
279 
 
100 % 
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0.40% 
0.40% 
0.40% 
0.40% 
0.40% 
0.40% 
0.70% 
0.70% 
0.70% 
0.70% 
1.10% 
1.10% 
1.40% 
1.40% 
1.40% 
2.90% 
3.20% 
3.20% 
4.70% 
6.80% 
7.30% 
8.60% 
16.50% 
17.60% 
17.90% 
0% 2% 4% 6% 8% 10% 12% 14% 16% 18% 20%
Enterococcus avium
Group C Streptococci
Group G Streptococci
Enterobacter cloacae
Pseudomonas fluorescens
Gram negative cocci
Granulicatellaadiacens
Streptococcus viridians
Citrobacter species
Providencia species
Enterobacter species
Proteus vulgaris
Enterococcus faecium
Streptococcus pyogenes
Morganella morganii
Enterobacter aerogenes
Citrobacter diversus
Others
Acinetobacterbaumannii
Enterococcus faecalis
Proteus mirabilis
Klebsiella pneumoniae
Pseudomonas aeruginosa
Staphylococcus aureus
Escherichia coli
Frequency distribution of all organisms 
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As stated earlier, the frequency distribution of patients with multidrug resistant organisms 
among the 150 patients included in the study, was 66%, being observed in 99 out of 150 
patients.  54.8 % (153 out of 279) of isolated organisms were multidrug resistant organisms.   
Antibiotic resistance was observed in 58.6% (115 out 196) of gram negative organisms 
compared to 45.78% (38 out of 83) in gram positive organisms.  Among the gram positive 
cocci, 55 % of Staphylococcus aureus species and 47.36 % of Enterococcus faecalis species 
were multidrug resistant.   
Among the gram negative bacilli, multidrug resistance was noted in 78% of Escherichia coli, 
74% of  Pseudomonas auroginosa, 70% of Proteus mirabilis and 61.53% of Acinitobacter 
baummanni, with lower percentages in other isolates.  Listing the multidrug resistant 
organisms isolated, MDR Pseudomonas aeruginosa was found to be the highest (34/153), 
followed by ESBL Escherichia coli (33/153).  
 However, when the number of ESBL + Amp C Escherichia coli are considered together 
along with ESBL Escherichia coli, this would be the highest.  (Tables 8&9) 
 
MDRO 
55% 
Non MDRO 
45% 
MDRO vs Non MDRO ( % of isolates ) 
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Table 8: Frequency distribution of multidrug resistant organisms 
ORGANISMS N  (%) MDRO  
N ( % ) 
 
Ulcers with 
MDRO (%) 
 
GRAM- POSITIVE COCCI 
Enterococcus avium 
Enterococcus faecalis 
Enterococcus faecium 
Granulicatella adiacens 
Staphylococcus aureus 
Group C Streptococci 
Group G Streptococci 
Streptococcus pyogenes 
Streptococcus viridans 
 
 
 
 
1   (0.4%) 
19 (6.8%) 
4   (1.4%) 
2   (0.7%) 
49 (17.6%) 
1   (0.4%) 
1   (0.4%) 
4   (1.4%) 
2   (0.7%) 
 
 
1 (100%) 
9 (47.36%)  
1 (25%) 
 
27 (55%) 
 
 
 
0.66% 
6% 
0.66% 
 
18% 
 
GRAM-NEGATIVE RODS 
Acinetobacter baumannii 
Citrobacter diversus 
Citrobacter species 
Enterobacter aerogenes 
Enterobacter cloacae 
Enterobacter species  
Escherichia coli 
Klebsiella pneumoniae 
Morganella morganii 
Proteus mirabilis  
Proteus vulgaris   
Pseudomonas aeruginosa 
Pseudomonas fluorescens 
Providencia species 
Others 
 
 
GRAM-NEGATIVE COCCI 
 
 
 
 
13 (4.7%) 
9   (3.2% 
2   (0.7%) 
8   (2.9%) 
1   (0.4%) 
3   (1.1%) 
50 (17.9%) 
24 (8.6%) 
4   (1.4%) 
20 (7.3%) 
3   (1.1%) 
46 (16.5%) 
1   (0.4%) 
2   (0.7%) 
9   (3.2%) 
 
 
1   (0.4%) 
 
 
 
8 (61.53%) 
3 (33.33%)  
 
3 (37.5%) 
 
 
39 (78%) 
10 (41.66%) 
2 (50%) 
14 (70%) 
 
34 (74%) 
 
2 (100%) 
 
 
 
5.3% 
2% 
 
2% 
 
 
26% 
6.6% 
1.3% 
9.3% 
 
22.6% 
 
1.3% 
 
TOTAL 
 
 
 
279 (100%) 
 
153 ( 54.8 % ) 
 
 
 
 
 
 
 
P a g e  | 45 
 
 
 
 
Table 9: List of Multidrug Resistant Organisms 
MDROs N PERCENT 
 
GRAM- POSITIVE COCCI 
Staphylococcus aureus ( MRSA ) 
Staphylococcus aureus ( MRCONS ) 
MDR Enterococcus avium  
MDR Enterococcus faecalis 
MDR Enterococcus faecium 
 
 
 
17 
10 
1 
9 
1 
 
 
6.1 % 
3.6 % 
0.4 % 
3.2 % 
0.4 % 
 
GRAM-NEGATIVE RODS 
Enterobacter aerogenes ( AMPC ) 
Escherichia coli ( ESBL ) 
Escherichia coli ( ESBL + AMPC ) 
Klebsiella pneumonia ( ESBL ) 
Proteus mirabilis ( ESBL )  
Proteus mirabilis ( AMPC ) 
MDR Acinetobacter baumannii 
MDR Citrobacter diversus 
MDR Morganella morganii 
MDR Pseudomonas aeruginosa 
MDR Providencia species 
 
 
 
3 
33 
6 
10 
13 
1 
8 
3 
2 
34 
2 
 
 
1.1 % 
11.8 % 
2.2 % 
3.6 % 
4.7 % 
0.4 % 
2.8 % 
1.07 % 
0.7 % 
12.18 % 
0.7 % 
 
TOTAL 
 
153 
 
54.9 % 
 
 
Pseudomonas 
10% 
E Coli 
10% 
Staphy aureus 
10% 
Others 
70% 
Isolates 
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0.40% 
0.40% 
0.40% 
0.70% 
0.70% 
1.07% 
1.10% 
2.20% 
2.80% 
3.20% 
3.60% 
3.60% 
4.70% 
6.10% 
11.80% 
12.18% 
0% 2% 4% 6% 8% 10% 12% 14%
MDR Enterococcus avium
MDR Enterococcus faecium
Proteus mirabilis ( AMPC )
MDR Morganella morganii
MDR Providencia species
MDR Citrobacter diversus
Enterobacteraerogenes ( AMPC )
Escherichia coli ( ESBL + AMPC )
MDR Acinetobacter baumannii
MDR Enterococcus faecalis
Staphylococcus aureus ( MRCONS )
Klebsiella pneumonia ( ESBL )
Proteus mirabilis ( ESBL )
Staphylococcus aureus ( MRSA )
Escherichia coli ( ESBL )
MDR Pseudomonas aeruginosa
Multi-drug resistant organisms 
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MDRO vs NON-MDRO INFECTED ULCERATIONS: 
The factors associated with MDRO infections were analysed.  The test variables were 
compared using Chi-square test for qualitative variables and Student’s test for quantitative 
variables.  The variables for which the association was statistically significant ( p< 0.1 ) were 
introduced in a logistic model to explain the presence of MDRO. 
Results of the univariate analysis showed , poor glycaemic control, previous hospitalisation, 
previous history of amputation, previous antibiotic usage, size of ulcer, necrotic ulcer, 
recurrent ulcers, higher grade of ulcer,presence of osteomyelitis, presence of retinopathy, 
peripheral vascular disease, neuropathy and polymicrobial culture, were significantly 
associated with MDRO infected foot ulcers. 
However logistic regression results indicated that only two factors significantly increased the 
chances of acquiring MDRO infection; recurrent ulcer (OR = 3.39, p < 0.05,        95 % CI = [ 
1.081 – 10.664 ] ), Higher grade of ulcer ( OR = 13.44, p < 0.001, 95 % CI = [   3.595 – 
50.278 ] ). 
The association of factors like age and sex of the patient, socio-economic status, type and 
duration of diabetes, presence of nephropathy, hypertension, smoking, alcohol, site and 
duration of the ulcer with MDRO infected ulcers were statistically insignificant. 
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Table 10: MDRO versus NON-MDRO 
 
NATURE OF 
ULCER  
Non necrotic 
Necrotic 
 
 
 
 
42 ( 53.8 % ) 
9 ( 12.5 % ) 
 
 
 
36 ( 46.2 % ) 
63 ( 87.5 % ) 
 
 
 
78 ( 100% ) 
72 ( 100 % ) 
 
 
 
28.52 
 
 
 
0.000 
RECURRENCE 
Non recurrent 
Recurrent 
 
 
 
42 ( 53.2 %) 
9 ( 12.7 % ) 
 
37 ( 46.8 % ) 
62 ( 87.3 % ) 
 
79 ( 100 % ) 
71 ( 100 % ) 
 
 
27.31 
 
 
0.000 
VARIABLE NON  
MDRO 
MDRO TOTAL X 
2
 P VALUE 
 
AGE 
< 40 
41 – 50  
51 – 60  
61 – 70  
71 – 80  
81 – 90  
 
 
3 ( 60 % ) 
8 ( 50 % ) 
14 ( 25.5 % ) 
22 ( 35.5 % ) 
4 ( 40 % ) 
0 ( 0 % ) 
 
 
 
2 ( 40 % ) 
8 ( 50 % ) 
41 ( 74.5 % ) 
40 ( 64.5 % ) 
6 ( 60 % ) 
2 ( 100 % ) 
 
 
 
5 ( 100 % ) 
16 ( 100 % ) 
55 ( 100 %) 
62 ( 100 % ) 
10 ( 100 % ) 
2 ( 100 % ) 
 
 
 
 
 
6.373 
 
 
 
 
0.272 
 
SEX 
Male 
Female 
 
 
 
35 ( 31.2 % ) 
16 ( 42.1 % ) 
 
 
 
77 ( 68.8 % ) 
22 ( 57.9 % ) 
 
 
 
112 ( 100 % ) 
38 ( 100 ) 
 
 
 
1.490 
 
 
0.222 
 
 
SOCIO ECO- 
STATUS 
Class I 
Class II 
Class III 
Class IV 
Class V 
 
 
 
 
14 ( 35.9 % ) 
23 (34.8 % ) 
12 ( 30.8 % ) 
2 ( 33.3 % ) 
0 ( 0 % ) 
 
 
 
25 ( 64.1 % ) 
43 ( 65.2 % ) 
27 ( 69.2 % ) 
4 ( 66.7 % ) 
0 ( 0 % ) 
 
 
 
 
39 ( 100 % ) 
66 ( 100 % ) 
39 ( 100 % ) 
6 ( 100 % ) 
0 ( 0 % ) 
 
 
 
 
 
 
0.266 
 
 
 
 
 
0.966 
 
 
TYPE OF 
DIABETES 
I 
II 
 
 
 
 
3 ( 50 % ) 
48 ( 33.3 % ) 
 
 
 
 
3 ( 50 % ) 
96 ( 66.7 % ) 
 
 
 
 
6 ( 100 % ) 
144 ( 100 % ) 
 
 
 
0.713 
 
 
 
0.398 
 
DEPTH OF ULCER 
Superficial 
Deep 
 
 
 
26 ( 28.3 % ) 
25 ( 43.1 % ) 
 
 
66 ( 71.7 % ) 
33 ( 56.9 % ) 
 
 
92 ( 100 % ) 
58 ( 100 % ) 
 
 
 
3.492 
 
 
 
0.062 
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GRADE OF 
ULCER 
Class I 
Class II 
Class III 
Class IV 
Class V 
 
 
 
15 ( 88.2 % ) 
26 ( 65 % ) 
3 ( 6.7 % ) 
6 ( 17.1 % ) 
1 ( 7.7 % ) 
 
 
2 ( 11.8 % ) 
14 ( 35 % ) 
42 ( 93.3 % ) 
29 ( 82.9 % ) 
12 ( 92.3 % ) 
 
 
17 ( 100 % ) 
40 ( 100 % ) 
45 ( 100 % ) 
35 ( 100 % ) 
13 ( 100 % ) 
 
 
 
 
62.83 
 
 
 
 
0.000 
 
RETINOPATHY 
Absent 
Present 
 
 
 
44 ( 38.9 % ) 
7 ( 18.9 % ) 
 
 
69 ( 61.1 % ) 
30 ( 81.1 % ) 
 
 
113 ( 100 % ) 
37 ( 100 % ) 
 
 
 4.978 
 
 
0.026 
 
NEPHROPATHY 
Absent 
Present 
 
 
 
29 ( 37.7 % ) 
22 ( 30.1 % ) 
 
 
48 ( 62.3 % ) 
51 ( 69.9 % ) 
 
 
77 ( 100 % ) 
73 ( 100 % ) 
 
 
0.946 
 
 
 
0.331 
 
OSTEOMYELITIS 
Absent 
Present 
 
 
 
43 ( 43.4 % ) 
8 ( 15.7 % ) 
 
 
56 ( 56.6 % ) 
43 ( 84.3 % ) 
 
 
99 ( 100 % ) 
51 ( 100 % ) 
 
 
11.549 
 
 
0.001 
 
ARTERIOPATHY 
Absent 
Present 
 
 
 
38 ( 48.1 % ) 
13 ( 18.3 % ) 
 
 
41 ( 51.9 % ) 
58 ( 81.7 % ) 
 
 
79 ( 100 % ) 
71 ( 100 % ) 
 
 
14.789 
 
 
0.000 
 
NEUROPATHY 
Absent 
Present 
 
 
 
20 ( 58.8 % ) 
31 ( 26.7 % ) 
 
 
14 ( 41.2 % ) 
85 ( 73.3 % ) 
 
 
34 ( 100 %  ) 
116 ( 100 % ) 
 
 
12.0 
 
 
0.001  
 
HYPERTENSION 
Absent 
Present 
 
 
 
19 ( 32.8 % ) 
32 ( 34.8 % ) 
 
 
39 ( 67.2 % ) 
60 ( 65.2 % ) 
 
 
58 ( 100 % ) 
92 ( 100 % ) 
 
 
0.065 
 
 
0.799 
 
GLYCEMIC 
CONTROL 
(HBA1C) 
6-7 %( GOOD ) 
7-8 % (FAIR  ) 
>8 % ( POOR ) 
 
 
 
 
 
 
17 ( 58.6 % ) 
23 ( 42.6 % ) 
11 ( 16.4 % ) 
 
 
 
 
12 ( 41.4 % ) 
31 ( 57.4 % ) 
56 ( 83.6 % ) 
 
 
 
 
29 ( 100 % ) 
54 ( 100 % ) 
67 ( 100 % ) 
 
 
 
 
18.84 
 
 
 
 
0.000 
VARIABLE NON 
MDRO 
MDRO TOTAL X
2
 P VALUE 
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VARIABLE 
NON 
MDRO 
MDRO TOTAL X
2
 P VALUE 
 
PREVIOUS 
ADMISSION 
Not  hospitalized 
Hospitalized 
 
 
 
 
 
32 ( 45.7 % ) 
19 ( 23.8 % ) 
 
 
 
38 ( 54.3 % ) 
61 ( 76.2 % ) 
 
 
 
70 ( 100 % ) 
80 ( 100 % ) 
 
 
 
8.026 
 
 
 
0.005 
 
SMOKING 
Non smoker 
Smoker 
 
 
 
30 ( 40 % ) 
21 ( 28 % ) 
 
 
45 ( 60 % ) 
54 ( 72 % ) 
 
 
75 ( 100 % ) 
75 ( 100 % ) 
 
 
2.406 
 
 
0.121 
 
ALCOHOLIC 
Non- alcoholic 
Alcoholic 
 
 
 
33 ( 37.5 % ) 
18 ( 29 % ) 
 
 
55 ( 62.5 % ) 
44 ( 71 % ) 
 
 
88 ( 100 % ) 
62 ( 100 % ) 
 
 
1.162 
 
 
0.281 
 
HISTORY OF 
AMPUTATION 
Absent 
Present 
 
 
 
 
45 ( 38.1 % ) 
6 ( 18.8 % ) 
 
 
 
73 ( 61.9 %) 
26 ( 81.2 % ) 
 
 
 
118 ( 100 % ) 
32 ( 100 % ) 
 
 
 
4.216 
 
 
 
0.040 
 
 
CULTURE 
Mono microbial 
Poly microbial 
 
 
 
31 ( 50 % ) 
20 ( 22.7 % ) 
 
 
31 ( 50 % ) 
68 ( 77.3 % ) 
 
 
62 ( 100 % ) 
88 ( 100 % ) 
 
 
12.05 
 
 
0.001 
 
SITE 
Plantar 
Margins 
Heel 
Inter digital 
Malleoli 
Leg 
Multiple  areas 
 
 
 
10 ( 62.5 % ) 
8 ( 33.3 % ) 
14 ( 33.3 % ) 
10 ( 31.2 % ) 
5 ( 27.8 % ) 
4 ( 25 % ) 
0 ( 0 % ) 
 
 
6 ( 37.5 % ) 
16 ( 66.7 % ) 
28 ( 66.7 % ) 
22 (68.8 % ) 
13 ( 72.2 % ) 
12 ( 75 % ) 
2 ( 100 % ) 
 
 
16 ( 100 % ) 
24 ( 100 % ) 
42 ( 100 % ) 
32 ( 100 % ) 
18 ( 100 % ) 
16 ( 100 % ) 
2 ( 100 % ) 
 
 
 
7.831 
 
 
 
0.251 
 
DURATION OF 
DIABETES 
(Years Mean ) 
( SD ) 
 
 
 
 
 
 
 
1.84 
( 0.94 ) 
 
 
 
2.02 
(1.02 ) 
  
 
t= 
1.032 
 
 
 
   0.30 
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VARIABLE 
NON 
MDRO 
MDRO TOTAL X
2
 P VALUE 
 
DURATION OF 
ULCER 
(Months Mean) 
( SD ) 
 
 
 
 
1.49 
(0.73) 
 
 
 
1.42 
(0.77 ) 
  
 
t = 
0.50 
 
 
   0.61 
 
SIZE OF THE 
ULCER 
(cm
2
 mean ) 
( SD ) 
 
 
 
2.47 
0.80 
 
 
2.91 
0.97 
  
 
t = 
2.76 
 
 
0.006 
 
 
 
 
 
 
 
Table 11: Logistic regression : MDRO Vs NON-MDRO  
 
 B S.E. Wald df Sig. Exp(B) 95% C.I.for EXP(B) 
Lower Upper 
 
 
Nature .172 .730 .056 1 .814 1.188 .284 4.970 
Recurrence 1.222 .584 4.382 1 .036 3.395 1.081 10.664 
Grade 2.599 .673 14.910 1 .000 13.445 3.595 50.278 
Retinopathy .221 .631 .123 1 .726 1.247 .362 4.292 
Osteomyelitis -.260 .672 .150 1 .699 .771 .206 2.880 
Pvd .540 .537 1.013 1 .314 1.716 .600 4.911 
Neuropathy -.275 .675 .166 1 .684 .760 .202 2.854 
hba1c 1.105 .631 3.062 1 .080 3.019 .876 10.403 
Prev-hospital .161 .608 .070 1 .791 1.175 .357 3.870 
His.ofampuation .630 .769 .672 1 .412 1.878 .416 8.481 
Prevantibiotics .267 .636 .176 1 .675 1.305 .376 4.537 
Culture .889 .523 2.884 1 .089 2.432 .872 6.783 
Size .293 .285 1.053 1 .305 1.340 .766 2.345 
Age -.005 .029 .029 1 .865 .995 .939 1.054 
Constant -3.418 2.054 2.767 1 .096 
.033 
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IMPACT OF MDROs : 
 
The mean duration of hospital stay in MDRO infections was 15.36 days and that of non-
MDRO infections was 8.88 days.  The difference was statistically significant ( p< 0.001 ). 
 
 
Table 12 : Mean duration of hospital stay : 
 
  
 
MDRO N Mean Std. Deviation Std. Error 
Mean 
          t      P value 
stay 
Non 
MDRO 
51 8.88 6.716 .940 
  
MDRO 99 15.36 10.536 1.059         3.992         0.000 
 
Presence of multi drug resistant organisms in the foot ulcers was associated with statistically 
significant increased frequency of amputations, both major and minor (p < 0.01). In the 
MDRO group 44.4 % of patients had some form of amputations, where as in non-MDRO 
group only 21.6 % of the patients had amputations.  
Table 13 : MDROs & Amputations : 
 NO 
AMPUTATION 
AMPUTATION      TOTAL        X 
2
       P 
VALUE 
 
NON 
MDRO 
 
MDRO  
 
 
40 ( 78.4 % ) 
 
55 ( 55.6 % ) 
 
11 ( 21.6 % ) 
 
44 ( 44.4 % ) 
 
51 ( 100 % ) 
 
99 ( 100 % ) 
 
 
7.585 
 
 
0.006 
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No Amputation 
78% 
Amputation 
22% 
Non MDRO 
No Amputation 
56% 
Amputation 
44% 
MDRO 
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WOUND HEALING : 
 
Based on the status of the ulcer at 10 weeks time the patients were grouped as healed and 
non-healed group. Healed group included the patients whose ulcers were completely healed 
and reduced in size. The rest were in the non-healed group.  60 patients were in healed group 
and 90 were in the non-healed group. 
By univariate analysis, nature of ulcer, recurrent ulcer, grade of ulcer, underlying 
osteomyelitis, PVD, site of ulcer, culture, size of the ulcer, presence of nephropathy, 
neuropathy and the glycemic control were significantly ( p < 0.05 ) associated with poor 
healing of the ulcer.  Depth of the ulcer and presence of retinopathy had borderline ( p<0.1 ) 
association with poor healing. 
 
Table 14 : Healed Vs Non-Healed group : 
VARIABLE 
 
HEALED NOT-
HEALED 
TOTAL X 
2
 P VALUE 
 
AGE 
< 40 
41 – 50  
51 – 60  
61 – 70  
71 – 80  
81 – 90  
 
 
 
2 ( 40 % ) 
7 ( 43.8 % ) 
18 ( 32.7 % ) 
28 ( 45.2 % ) 
5 ( 50 % ) 
0 ( 0 % ) 
 
 
3 ( 60 % ) 
9 ( 56.2 % ) 
37 ( 67.3 % ) 
34 ( 54.8 % ) 
5 ( 50 % ) 
2 ( 100 % ) 
 
 
5 ( 100 % ) 
16 ( 100 % ) 
55 ( 100 %) 
62 ( 100 % ) 
10 ( 100 % ) 
2 ( 100 % ) 
 
 
 
 
3.744 
 
 
 
 
0.587 
 
SEX 
Male 
Female 
 
 
 
45 ( 40.2 % ) 
15 ( 39.5 % ) 
 
 
67 ( 59.8 % ) 
23 ( 60.5 % ) 
 
 
112 ( 100 %) 
38 ( 100 ) 
 
 
0.006 
 
 
 
0.939 
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VARIABLE 
 
HEALED NOT-
HEALED 
TOTAL X 
2
 P VALUE 
 
SOCIO ECO- 
STATUS 
Class I 
Class II 
Class III 
Class IV 
Class V 
 
 
 
 
20 ( 51.3 % ) 
22 (33.3 % ) 
14 ( 35.9 % ) 
4 ( 66.7 % ) 
0 ( 0 % )  
 
 
 
19 ( 48.7 % ) 
44 ( 66.7 % ) 
25 ( 64.1 % ) 
2 ( 33.3 % ) 
0 ( 0 % ) 
 
 
 
39 ( 100 % ) 
66 ( 100 % ) 
39 ( 100 % ) 
6 ( 100 % ) 
0 ( 0 % ) 
 
 
 
 
5.34 
 
 
 
 
 
0.148 
 
 
TYPE OF 
DIABETES 
I 
II 
 
 
 
 
2 ( 33.3 % ) 
58 ( 40.3 % ) 
 
 
 
 
4 ( 66.7 % ) 
86 ( 59.7 % ) 
 
 
 
 
6 ( 100 % ) 
144 ( 100 %) 
 
 
 
 
0.116 
 
 
 
 
0.734 
 
 
DEPTH OF ULCER 
Superficial 
Deep 
 
 
 
36 ( 39.1 % ) 
24 ( 41.4 % ) 
 
 
56 ( 60.9 % ) 
34 ( 58.6 % ) 
 
 
92 ( 100 % ) 
58 ( 100 % ) 
 
 
 
0.075 
 
 
0.062 
 
NATURE OF 
ULCER  
Non necrotic 
Necrotic 
 
 
 
49 ( 62.8 % ) 
11 ( 15.3 % ) 
 
 
29 ( 37.2 % ) 
61 ( 84.7 % ) 
 
 
78 ( 100% ) 
72 ( 100 % ) 
 
 
35.26 
 
 
0.000 
 
RECURRENCE 
Non recurrent 
Recurrent 
 
 
 
42 ( 53.2 %) 
18 ( 25.4 % ) 
 
 
37 ( 46.8 % ) 
53 ( 74.6 % ) 
 
 
79 ( 100 % ) 
71 ( 100 % ) 
 
 
12.05 
 
 
0.001 
 
GRADE OF ULCER 
I 
II 
III 
IV 
V 
 
 
 
16 ( 94.1 % ) 
26 ( 65 % ) 
14 ( 31.1 % ) 
4 ( 11.4 % ) 
0 ( 0 % ) 
 
 
1 ( 5.9 % ) 
14 ( 35 % ) 
31 ( 68.9 % ) 
31 ( 88.6 % ) 
13 ( 100 % ) 
 
 
17 ( 100 % ) 
40 ( 100 % ) 
45 ( 100 % ) 
35 ( 100 % ) 
13 ( 100 % ) 
 
 
 
53.21 
 
 
 
0.000 
 
RETINOPATHY 
Absent 
Present 
 
 
 
50 ( 44.2 % ) 
10 ( 27 % ) 
 
 
63 ( 55.8 % ) 
27 ( 73 % ) 
 
 
113 ( 100 %) 
37 ( 100 % ) 
 
 
3.44 
 
 
0.063 
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VARIABLE 
 
HEALED NOT-
HEALED 
TOTAL X 
2
 P VALUE 
 
NEPHROPATHY 
Absent 
Present 
 
 
 
37 ( 48.1 % ) 
23 ( 31.5 % ) 
 
 
40 ( 51.9 % ) 
50 ( 68.5 % ) 
 
 
77 ( 100 % ) 
73 ( 100 % ) 
 
 
4.27 
 
 
0.046 
 
OSTEOMYELITIS 
Absent 
Present 
 
 
 
54 ( 54.5 % ) 
6 ( 11.8 % ) 
 
 
45 ( 45.5 % ) 
45 ( 88.2 % ) 
 
 
99 ( 100 % ) 
51 ( 100 % ) 
 
 
25.668 
 
 
0.000 
 
ARTERIOPATHY 
Absent 
Present 
 
 
 
45 ( 57.0 % ) 
15 ( 21.1 % ) 
 
 
34 ( 43.0 % ) 
56 ( 78.9 % ) 
 
 
79 ( 100 % ) 
71 ( 100 % ) 
 
 
20.008 
 
 
0.000 
 
NEUROPATHY 
Absent 
Present 
 
 
 
25 ( 73.5 % ) 
35 ( 30.2 % ) 
 
 
9 ( 26.5 % ) 
81 ( 69.8 % ) 
 
 
34 ( 100 %  ) 
116 ( 100 %) 
 
 
20.59 
 
 
0.000  
 
HYPERTENSION 
Absent 
Present 
 
 
 
22 ( 37.9 % ) 
38 ( 41.3 % ) 
 
 
36 ( 62.1 % ) 
54 ( 58.7 % ) 
 
 
58 ( 100 % ) 
92 ( 100 % ) 
 
 
0.169 
 
 
0.681 
 
GLYCEMIC 
CONTROL 
(HBA1C) 
6-7 %( GOOD ) 
7-8 % (FAIR  ) 
>8 % ( POOR ) 
 
 
 
 
 
21 ( 72.4 % ) 
31 ( 57.4 % ) 
8 ( 11.9 % ) 
 
 
 
 
8 ( 27.6 % ) 
23 ( 42.6 % ) 
59 ( 88.1 % ) 
 
 
 
 
29 ( 100 % ) 
54 ( 100 % ) 
67 ( 100 % ) 
 
 
 
 
41.49 
 
 
 
 
0.000 
 
PREVIOUS 
HOSPITALIZATION 
Not Hospitalized 
Hospitalized 
 
 
 
 
33 ( 47.1 % ) 
27 ( 33.8 % ) 
 
 
 
37 ( 52.9 % ) 
53 ( 66.2 % ) 
 
 
 
70 ( 100 % ) 
80 ( 100 % ) 
 
 
 
2.79 
 
 
 
0.095 
 
SMOKING 
Non smoker 
Smoker 
 
 
 
34 ( 45.3 % ) 
26 ( 34.7 % ) 
 
 
41 ( 54.7 % ) 
49 ( 65.3 % ) 
 
 
75 ( 100 % ) 
75 ( 100 % ) 
 
 
1.778 
 
 
0.182 
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VARIABLE 
 
HEALED NOT-
HEALED 
TOTAL X 
2
 P VALUE 
 
H/0 AMPUTATION 
Absent 
Present 
 
 
 
49 ( 41.5 % ) 
11 ( 34.4 % ) 
 
 
69 ( 58.5 %) 
21 ( 65.6 % ) 
 
 
118 ( 100%) 
32 ( 100 % ) 
 
 
0.536 
 
 
0.464 
 
ALCOHOLIC 
Non- alcoholic 
Alcoholic 
 
 
 
38 ( 43.2 % ) 
22 ( 35.5 % ) 
 
 
50 ( 56.8 % ) 
40 ( 64.5 % ) 
 
 
88 ( 100 % ) 
62 ( 100 % ) 
 
 
0.898 
 
 
0.343 
 
SITE 
Plantar 
Margins 
Heel 
Inter digital 
Malleoli 
Leg 
Multiple  areas 
 
 
 
10 ( 62.5 % ) 
9 ( 37.5 % ) 
18 ( 42.9 % ) 
6 ( 18.8 % ) 
12 ( 66.7 % ) 
4 ( 25 % ) 
1 (5 0 % ) 
 
 
6 ( 37.5 % ) 
15 ( 62.5 % ) 
24 ( 57.1 % ) 
26 (81.2 % ) 
6 ( 33.3 % ) 
12 ( 75 % ) 
1 ( 50 % ) 
 
 
16 ( 100 % ) 
24 ( 100 % ) 
42 ( 100 % ) 
32 ( 100 % ) 
18 ( 100 % ) 
16 ( 100 % ) 
2 ( 100 % ) 
 
 
 
 
16.51 
 
 
 
 
0.011 
 
PREVIOUS 
ANTIBOTIC 
USAGE 
Absent 
Present 
 
 
 
 
38 ( 44.2 % ) 
22 ( 34.4 % ) 
 
 
 
48 ( 55.8 % )  
42 ( 65.6 % ) 
 
 
 
86 ( 100 % ) 
64 ( 100 % ) 
 
 
 
1.472 
 
 
 
0.225 
 
CULTURE 
Mono microbial 
Poly microbial 
 
 
35 ( 56.5 % ) 
25 ( 28.4 % ) 
 
 
27 ( 43.5 % ) 
63 ( 71.6 % ) 
 
 
62 ( 100 % ) 
88 ( 100 % ) 
 
 
 
11.91 
 
 
0.001 
 
DURATION OF  
DIABETES 
(Years Mean ) 
( SD ) 
 
 
 
 
1.83 
( 0. 886) 
 
 
 
2.04 
(1.059 ) 
  
 
 
t= 
1.275 
 
 
 
0.204 
 
DURATION OF 
ULCER 
(Months Mean) 
( SD ) 
 
 
 
 
1.52 
(0.770) 
 
 
 
1.40 
(0.747 ) 
  
 
 
t = 
0.926 
 
 
 
   0.356 
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VARIABLE 
 
HEALED NOT-
HEALED 
TOTAL X 
2
 P VALUE 
 
SIZE OF THE 
ULCER 
(CM
2 
Mean ) 
( SD ) 
 
 
 
2.5 
0.893 
 
 
2.93 
0.934 
  
 
t = 
2.834 
 
 
  0.005 
 
DRUG 
RESISTANCE 
MDRO 
NON MDRO 
 
 
 
 
24 ( 24.2 % ) 
36 ( 70.6 % ) 
 
 
 
75 ( 75.8 % ) 
15 (29.4 % ) 
 
 
 
99 ( 100 % ) 
51 ( 100 % ) 
 
 
 
30.12 
 
 
 
0.000 
 
Table 15 : Logistic regression:  
 
 B S.E. Wald df Sig. Exp(B) 95% C.I.for EXP(B) 
Lower Upper 
Step 1
a
 
ageno -.060 .033 3.228 1 .072 .942 .882 1.005 
size .297 .339 .768 1 .381 1.346 .693 2.617 
depth(1) -.157 .673 .054 1 .816 .855 .228 3.199 
nature(1) .775 .745 1.081 1 .298 2.170 .504 9.353 
recurrence(1) -.996 .702 2.016 1 .156 .369 .093 1.461 
retinopathy(1) -.780 .717 1.182 1 .277 .459 .112 1.870 
nephropathy(1) 1.474 .648 5.174 1 .023 4.369 1.226 15.564 
osteomyelitis(1) 2.114 .788 7.202 1 .007 8.280 1.768 38.766 
pvd(1) 2.063 .697 8.766 1 .003 7.872 2.009 30.849 
neuropathy(1) .391 .727 .290 1 .590 1.479 .356 6.145 
site   10.174 6 .118    
site(1) -.842 1.166 .522 1 .470 .431 .044 4.231 
site(2) -1.233 1.104 1.246 1 .264 .292 .033 2.540 
site(3) .800 1.164 .472 1 .492 2.226 .227 21.819 
site(4) -2.612 1.261 4.290 1 .038 .073 .006 .869 
site(5) -.638 1.379 .214 1 .644 .528 .035 7.883 
site(6) -2.416 2.353 1.054 1 .304 .089 .001 8.987 
culture(1) .927 .597 2.411 1 .120 2.527 .784 8.147 
mdro(1) 1.109 .754 2.163 1 .141 3.031 .691 13.283 
hba1c1 1.795 .806 4.959 1 .026 6.020 1.240 29.226 
grade1 1.413 .796 3.150 1 .076 4.107 .863 19.549 
Constant -1.638 2.330 .494 1 .482 .194   
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However logistic regression showed only the following factors, significantly delayed the 
chances of wound healing : PVD ( OR = 7.872, p < 0.01, 95 % CI = [2.009 – 30.849 ] ), 
Osteomyelitis ( OR = 8.280, p<0.01, 95 % CI = [ 1.768 – 38.766 ]), Presence of nephropathy 
( OR = 4.36, p < 0.05, 95 % CI = [ 1.226 – 15.564 ]), Inter-digital / digital ulcer ( OR = 
0.073, p < 0.05 , 95 % CI = [ 0.006 – 0.869 ]), HbA1c ( OR = 6.020, p < 0.05, 95 % CI = [ 
1.240 – 29.226 ]), Age ( OR = 0.942, p <0.1, 95 % CI = [ 0.882 – 1.005 ]), Grade of ulcer ( 
OR = 4.10, p <0.1, 95 % CI = [ 0.863 – 19.549]) . 
MDR infected ulcers had no impact on wound healing. Other factors like socio-economic 
status, type of diabetes, smoking, alcohol, duration of ulcer had no role in determining the 
wound healing. 
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DISCUSSION 
 
This study presents a comprehensive clinical and microbiological profile of infected diabetic 
foot ulcers, especially in relation to multidrug resistant organisms. As already discussed India 
is the diabetic capital of the world
2
, and South India is the diabetic capital of India.  With 
some reports of nearly 20% of hospital admissions being infected diabetic foot ulcers 
11
 and 
with the growing global problem of multidrug resistant organisms
68
, we made an effort to 
study the role of multidrug resistant organisms in relation to diabetic foot ulcers, here at 
Coimbatore. 
In our study the foot ulcers were more prevalent in the fifth and sixth decade of life. The 
average age of the patients with foot ulcer was 58.21 ± 9.3 years, which is similar to the age 
prevalence described in other Indian studies 
12,69,70,71
 .  The foot ulcers were more common in 
male than female, which may be due to higher level of manual work and outdoor activity 
among male when compared to females. Similar gender preponderance was observed in 
studies conducted in India 
12,72
.  
In our study, most of the patients with ulcer had diabetes of less than 5 years duration. This 
observation was in contrast with other studies conducted in the country 
12,72
  which showed 
more ulcers occurring in patients having diabetes for longer duration.  This might well reflect 
the profile of all diabetic patients visiting the hospital, and will need an in depth examination 
to ascertain this. 
Most of the patients (68%) had ulcers of less than 1 month duration which is similar to the 
observations from a north Indian study
72
. But according to another north Indian study
12
 most 
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ulcers presented to hospital after 3 months.  An early presentation is often due to the fact that 
ulcers with acute onset often have systemic symptoms which bring the patients to the 
hospital, while in chronic ulcers the symptoms are mild and localised. 
Comparable with the literature 
12,72
, most of the patients in the present study had poor 
glycaemic control.  Poor glycaemic control is associated with greater degree of microvascular 
complications.   
Majority of the patients in our study had higher grade of ulcers (Wagners grade III or worse) 
similar to the other north Indian studies 
12,72
. The reason for presentation with higher grade 
could be because of lack of structured health care delivery in the country, attempted self 
medication and trust in traditional healers
73
. 
In the present study the neuropathy was seen in 77.33% of the diabetic foot ulcer patients.  
The other studies reported from India 
12,72,11
  showed a similar high prevalence ( 86.2% , 
66.6%, and 56.8 % respectively).Whereas studies done in other countries showed a varied 
prevalence. A Nigerian study 
10
 showed prevalence of 77.8%.  An UAE 
74
study showed 39% 
prevalence. Mauritius study 
76
 and Jordan study
77
 showed a prevalence of  12.7% and  19% 
respectively.European studies
75,78,79
have a shown a prevalence ranging from 32 to 33.5% .  
This marked variation in the prevalence may be due to varied methods used for diagnosing 
neuropathy(monofilament testing ,biothesiometer, scoring systems ).  However, this does 
show a higher prevalence in Indian population. This could be because of patient’s ignorance 
and poor glycemic control. 
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In our study, the prevalence of retinopathy was 24.66%.  This observation was similar to 
another south Indian study
11
 which showed a prevalence of 25.9%.  But the studies conducted 
in northern Indian 
72,12
 showed a higher prevalence – 52.7% and 72.5% respectively. Thus the 
prevalence is lower in south India when compared to other countries.  This is in line with the 
overall lower prevalence of diabetic retinopathy in southern India
80
.  Prevalence of 
retinopathy among foot ulcer patients in studies from Jordan
77
, France 
81
, Hong Kong 
82
, and 
Italy 
83
 were 45%, 37.23%, 36%, and 49.4% respectively. 
12.70% 
19% 
32% 
32.30% 
33.50% 
37% 
39% 
56.80% 
66.60% 
77.33% 
77.80% 
86.20% 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Mauritius
Jordan
Portugal
Italy
Greece
France
UAE
chennai
Aligarh
our study
Nigeria
Delhi
Prevalence of Neuropathy 
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Peripheral arterial disease was observed in 47.33% of our study group.  The other previously 
reported studies showed highly variable results. A north indian study
12 
 showed a very high 
prevalence of 85%.  On the other hand the study from south India 
11
 showed a prevalence of 
10.3%.  Similarly the prevalence varied between countries also,  Nigeria
84
 – 76.4%,  
Bahrain
85
 – 11.8%,  UAE74 – 12%, Thailand 86– 2%, Honkong82 – 0%. 
24.66% 
25.90% 
36% 
37.23% 
45% 
49.40% 
52.70% 
72.50% 
0% 10% 20% 30% 40% 50% 60% 70% 80%
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Delhi
Prevalence of Retinopathy 
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The prevalence of nephropathy was 48.66% in our study. The north indian study
12
 showed a 
high prevalence( 75% ).  A study from south India showed 27.2 %
11
. Studies from other 
countries also showed a lower prevalence, Jordan
77
 – 33%, Honkong82 – 20%, Italy83 – 
10.9%. 
The bacteriological evaluation of diabetic foot ulcer from our study showed that the gram 
negative organisms were found have a higher occurrence than gram positive organisms in the 
ratio 2.3 :1.  Some of the other Indian studies
12,72,11
also showed a higher occurrence of gram 
negative organisms with  ratios of 1.5 : 1
12
, and 1.3: 1
72
. Comparatively our study did show a 
higher ratio.  A study from Malaysia
64
 also showed the same.  However, most of the western 
literature showed a predominance of gram positive organisms as supposed to gram negative 
organisms 
22,50,81,87,88
. This  could be partly due to differences in the causative organisms 
occurring over time, geographical variations, or the types and severity of infection included 
in the studies 
89
. 
Diabetic foot infection are usually polymicrobial in nature which is well documented in 
literature. In our study, 58.66 % of ulcers had polymicrobial culture. Similar observations 
were found in other Indian studies(Gadepalli et al
12
, Mohammed zubair et al
72
, Shankar et 
al
11
, Vishwanathan et al
65
 )and western studies ( Dian M Citron et al
89
, Wright-Poscoe
90
 et 
al.).  There are however a few studies (Dhanasekarenet al
91
 and Sajeed et al
64
)which showed 
more patients with monomicrobial culture.  Polymicrobial infection, to a certain extent, may 
be due to prior treatment history of the patients studied, as reported earlier 
39,52,92
. 
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In our study, the rate of isolation of organism per ulcer was 1.86 while the other two 
indianstudies( Mohammed et al 
72
, Gadepalli
 12
) showed a rate of 1.25 and 2.3 organisms per 
ulcer. A study from Malaysian reported
64
 1.47 org / lesion. A study from US
38
 by Gerding et 
al, showed a very high rate of 5.8 organisms recovered from the ulcer. 
 
The commonest organism isolated in our study was Escherechia coli followed by 
Staphylococcus aureus, Pseudomonas and Klebsiella pneumoniae. This is similar to the 
observations from a south  indian study
65
.  Another south Indian study
11
, showed 
Pseudomonas aeruginosa as the commonest isolate. But most of the other studies from 
India
72,12
 and other countries
89,64,81
showed Staphylococcus aureus as the commonest isoloate 
from diabetic foot ulcers.    
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In our study, the third predominant organism was Pseudomonas ( 16.5 % ). Two other 
studies
81,11
  also showed higher recovery of Pseudomonas.  The gram negative bacilli, 
Pseudomonas, which were once considered as normal flora of the skin, may cause severe 
tissue damage in diabetics and should never be regarded as insignificant in diabetic foot 
ulcers
93
. 
In our study 66 % of the ulcers grew multi-drug resistant organisms (MDRO) and 54.8% of 
isolated organisms were multi drug resistant. Many different definitions for multi-drug 
resistant organisms were used in medical literature. Due to the lack of uniform definition for 
MDROs the overall prevalence of MDRO, as seen in the literature, could not be studied. 
European centre for disease prevention and control has arrived at a definition for MDROs and 
has laid up specific criteria for categorising an organism as MDRO
67
. 
Apart from the multi drug resistant organisms like MRSA, ESBL, VRE which were 
extensively studied in literature, other groups of organisms like MDR Psudomonas, 
Acinetobacter, Enterococcus, Enterobactereciae etc were also identified in our study.  The 
higher prevalence of multidrug resistant organisms was also observed in another north Indian 
study (Gadepalliet al
12
). The higher degree of antibiotic resistance in tertiary care hospitals, 
could be because, with widespread usage of broad spectrum antibiotics, there occurs selective 
survival of drug resistant organisms.  Western literature ( Richard et al 
81– 22  % of isolate 
,Kandemir O et al 
94
-  40.38 % ) showed a lower prevalence of MDRO when compared to 
Indian literature, perhaps a reflection of higher antibiotic use and abuse.  The increasing 
occurrence of MDROs is disconcerting because, infection with these organisms limits the 
choice of antibiotic treatment and may lead to a worse outcome. 
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Our study showed that 75% of all MDROs isolated were gram negative organisms.  It is a 
fact that higher degree of antibiotic resistance is observed in gram negative organisms when 
compared to gram positive organisms.  This is because gram negative organisms have a 
unique outer membrane which does not allow certain antibiotics to penetrate. 
55% (27 out of 49 isolates) of Staphylococcus aureus isolated from our study were 
methicillin resistant.  A similar observation was found in the north Indian study 
72 
, which 
showed  57.1%, and in the south Indian study alluded to earlier, it was 42% 
11
.  But studies 
from other countries showed a lower percentage.  A study done in France showed (Richard et 
al
81
 ) 37.4%.  2 studies done in UK (Tentalouris et al 
50
, Dang C N et al
22 
) showed 40% and 
30% respectively.  A much lower percentage (16%) was observed in a Malaysian study
64
. 
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MRSA was seen in 18% of the patients in our study.  These results were similar to the 
previous Indian studies.  17.5% and 23.3% were seen respectively in the two north Indian 
studies ( Gadepalli et al 
12
 ) & ( MohammedZubair et al 
72
 ).  A study done in South India ( 
Shankar et al 
11
) had an occurrence of 10.3%. The studies from the west , France ( Richard et 
al
81
, Hartemann et al
60
 ), UK (Dang C N et al 
22,
Tentalorius et al
50
) showed 19.7%, 16%, 
30%, 11.5% respectively .  
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20.4 % of isolated staphylococcus aureus were Methicillin resistant and coagulase negative 
(MRCONS ), the reports of which in relation to diabetic ulcers were not looked at in the 
previous studies.  In our study we also identified other multi drug resistant gram positive 
organisms such as MDR Enterococcus avium, Enterococcus faecalis, and Enterococcus 
faecium, in relation to diabetic foot ulcers (using the guidelines proposed by European centre 
for disease prevention and control
67
).  These were not observed in previous studies. 
With regard to the gram negative organisms in our study, E.coli showed greater antibiotic 
resistance, followed by Pseudomonas aeruginosa.  78 % of isolated E.coli and 74 % of 
isolated Pseudomonas were multi-drug resistant.   
10.30% 
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In the last two decades, we have seen the emergence of extended spectrum beta lactamase 
(ESBL) producing gram negative organisms, which have often posed therapeutic challenges.  
All multi drug resistant E.coli, in our study, were ESBL producers and 12 % produced both 
ESBL and AmpC.  41.66 % of isolated Klebsiella pneumoniae were ESBL producers.  65 % 
of Proteus mirabilis were ESBL producers (check table 8).  62 out of the 196 gram negative 
isolates (31.63%) were ESBL producers, which were isolated from 26.59 % of the ulcers in 
our study.  The previous study done at north India
12
 showed that 54.5 % of E.coliwere ESBL 
producers.  The other study 
72
 has showed that 54.6 % of E.coli and 55.8 % of Klebsiella 
pneumoniae were ESBL producers.  The study from Brazil 
95
 showed 6 % of isolated E.coli 
were ESBL producers.  The study from France 
81
 has showed 26.9% of Pseudomonas were 
multi-drug resistant.  In our study 4.7 % of isolated organisms were Acinetobacter baumanii 
and 61.5 % of these were multidrug resistant.  In the study from France 
81
  25 % of isolated 
Acenetobacter baumanii were multi-drug resistant.   
Among the isolated multi-drug resistant organisms, 25.49 % were MDR E.coli, followed by 
22.22 % MDR Pseudomonas aeruginosa, 17.64 % methicillin resistant Staphylococcus 
aureus.  Thus MDROs appear to be firmly entrenched in our patients, and posing questions to 
clinicians and microbiologists alike, with regard to patient management and the development 
of antibiotic policies. 
In our study, univariate analysis showed that, poor glycaemic control, previous 
hospitalisation, previous history of amputation, previous antibiotic usage, size of ulcer, 
necrotic ulcer, recurrent ulcers, higher grade of ulcer, presence of osteomyelitis, presence of 
retinopathy, peripheral vascular disease, neuropathy and polymicrobial culture, were 
significantly associated with MDRO infected foot ulcers. 
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 However, analysis by logistic regression revealed that only the recurrent ulcers and higher 
grade of ulcers were significantly associated with multi-drug resistant organism infections.  It 
is possible that patients with recurrent ulcers have had several courses of antibiotics, both 
during previous hospital admissions and from practitioners in the community, which led to 
resistance to multiple antibiotics.  Higher grade of ulcers have an associated systemic sepsis 
and excessive local necrotic tissues.  
Another study from India
12
 showed that presence of neuropathy and ulcer size > 4 cm
2
 were 
significantly associated with multi-drug resistant organism infections.   The two significant 
factors associated with MDRO, in a study from France 
81
were, previous hospitalization and 
proliferative retinopathy.  Previous hospitalisation was again significantly associated in 
another study from France 
60
.  
Factors like previous hospitalization, previous antibiotic usage, poor glycemic control, 
ischemic ulcers have emerged as possible risk factors for MDRO in several other 
studies
12,60,81
.  However, we have not found any significant association in our study.  
Although we have identified a few factors associated with MDRO, the effect of diabetes 
related immunopathology has not been studied.  This and its possible impact on infection are 
still a matter of debate 
96.
 
In our study, the presence of MDRO in foot ulcers, significantly increased the duration of 
hospital stay and the associated cost.  The mean duration of hospital stay in MDRO infected 
ulcer group was 15.36 days and that of non-MDRO group was 8.8 days.  Interestingly, the 
other two Indian studies ( Gadepalli et al 
12
, Mohammed zubair
72 
) found no difference in the 
duration of hospital stay with MDRO infected ulcers. 
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Patients with MDRO had an increased the rate of amputations both major and minor, in our 
study.  Similar observations were found in the north Indian study ( Mohammedzubair  et al 
72
 
) and one from France ( Richard et al 
81
).  We have seen that MDRO infections are associated 
with higher grade ulcers, and this could offer an explanation for the increased amputations. 
We also made an effort to analyse the factors involved in determining the healing time of 
infected foot ulcers.  We found by multi-variate analysis, the factors which determine the 
wound healing were, the age, presence of peripheral arterial disease, osteomyelitis, 
nephropathy, interdigital ulcers,  poorglycaemic control and grade of ulcer.   
Although found significant by univariate analysis, the presence of MDRO had no  role in 
determining the wound healing.  This could be because of prompt change of antibiotics as 
dictated by the culture and sensitivity reports.  Similarly other factors like smoking, size and 
depth of ulcers, duration of diabetes had no role in influencing the duration of wound healing.  
Similar observations were found in the study from France 
81
,  which also showed no role of 
MDRO in wound healing.  The same study reported that the presence neuro-ischaemic ulcers, 
proliferative retinopathy, and glycaemic control were the determining factors.  Similar reports 
were observed from other studies ( Harteman et al 
60
, game et al
97
 ).  Wound depth, presence 
of neuropathy and peripheral arterial disease have been reported to influence wound healing 
98,99
 . But few studies ( Tentolorius et al 
50
, Wagner et al 
100
 ) have reported that the presence 
of MRSA, does have a role in prolonging the wound healing time. 
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CONCLUSION 
 
 The prevalence of multi-drug resistant organisms is alarmingly high in infected 
diabetic foot ulcers. 
 Recurrent ulcers are more prone to acquire multi-drug resistant organisms. 
 Higher grade of ulcers are more prone to acquire multi-drug resistant organisms. 
 Escherichia coli is commonest isolate from all the ulcers 
 ESBL Escherichia coli is the commonest multi-drug resistant organism derived from 
infected diabetic foot ulcer. 
 Multi-drug resistant organisms in diabetic foot ulcers are associated with longer 
duration of hospital stay. 
 Rate of amputations are significantly higher with multi-drug resistant organism 
infected diabetic foot ulcers. 
 Multi-drug resistant organisms have no significant impact on wound healing. 
  Presence peripheral arterial disease, osteomyelitis, nephropathy, inter-digital / digital 
ulcers,  higher grade of ulcer and poor glycemic control delay the healing of foot 
ulcer.  
 Prevalence of micro-vascular complications are high in our country. 
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RECOMMENDATIONS 
 
There is a paucity of data regarding the actual burden of multi-drug resistant organisms in 
diabetic foot ulcers in our country. The findings from the present study suggest that 
prospective multicentre studies have to be done to assess the nationwide prevalence and to 
frame an effective antibiotic policy.  The study also directs us to manage the diabetic foot 
ulcers with appropriate antibiotics adhering to the institutional antibiotic policy along with 
effective glycemic control to decrease the incidence of multi-drug resistant organisms.   
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 Ip . no age sex ses yrs ulcer stay size depth na 
ture 
recur grade eye kidney bone pvd nerve sht Rx HE 
AL 
dis hba1c hosp sm 
oke 
alc 
ohol 
ampute site antibio cul 
ture 
mdro 
i11004541 52 1 3 1 1 26 5 1 2 0 5 1 1 0 1 1 0 3 5 1 1 0 1 1 0 7 0 1 1 
i11013626 63 1 3 1 1 14 4 1 2 0 4 1 0 0 1 1 0 2 2 1 1 1 1 1 0 7 0 2 1 
i11013873 62 1 2 3 1 11 3 1 2 1 4 0 0 1 1 1 1 3 5 1 3 1 1 1 0 4 1 2 0 
i11016215 25 1 2 2 2 4 3 1 1 0 2 0 0 0 0 0 1 1 1 1 2 0 0 0 0 5 0 2 1 
i11023590 49 2 3 2 2 30 3 2 2 1 4 1 1 1 0 1 1 2 3 1 1 1 0 0 0 2 1 2 0 
i11029803 64 1 2 3 1 16 4 1 2 1 5 0 0 1 1 1 0 4 6 1 3 1 1 1 0 5 0 2 1 
i11034531 58 1 3 2 4 10 3 1 1 1 3 0 0 0 1 1 1 1 2 1 2 1 1 1 0 3 0 1 1 
i11003371 71 1 2 2 1 27 2 1 2 0 3 0 1 0 1 1 1 2 2 1 1 1 1 0 1 5 0 1 1 
i11003390 60 2 1 1 1 20 2 1 2 0 2 0 0 1 1 1 1 2 3 1 2 0 0 0 0 3 0 2 1 
i11000160 60 2 1 1 1 13 2 1 1 0 2 0 0 0 1 0 0 2 2 1 2 1 0 0 0 6 1 1 0 
i11019583 60 1 1 2 2 4 1 1 1 1 1 0 0 1 1 1 1 1 2 1 1 1 0 1 1 6 1 2 0 
i11033672 69 1 2 2 1 15 2 1 1 1 1 0 0 1 0 1 0 2 3 1 2 1 1 1 1 1 1 2 1 
i11016485 75 2 3 3 1 3 2 1 1 0 1 0 1 0 0 1 0 2 2 1 2 1 0 0 0 1 1 1 0 
i11028370 57 1 2 1 1 10 4 1 2 0 3 0 0 0 1 1 1 2 3 1 3 0 0 0 0 6 0 2 1 
i11035742 49 1 1 2 2 4 3 1 1 0 3 1 1 1 0 0 1 1 2 1 2 1 1 1 0 3 1 2 1 
i11013769 50 1 2 3 1 6 1 1 1 0 5 0 0 0 1 1 1 3 5 1 3 1 1 1 0 2 1 1 1 
I11013871 59 1 3 2 1 30 4 1 1 1 5 1 0 1 1 1 1 4 6 1 3 1 1 1 0 3 1 2 1 
i11035052 52 1 1 3 2 4 2 1 1 1 2 1 0 0 1 0 1 1 2 1 2 1 1 0 0 5 1 2 1 
i11004368 38 2 2 1 2 12 3 2 2 1 4 0 0 1 1 1 0 2 3 1 3 1 0 0 0 3 1 2 0 
i11012036 64 1 3 1 2 30 5 1 2 1 3 0 0 0 1 1 0 2 3 1 3 1 1 1 0 2 0 1 1 
i11013873 62 1 2 3 2 11 2 1 1 0 2 0 0 0 0 0 1 1 2 1 3 0 1 0 0 1 1 1 0 
i11014083 58 2 3 2 1 7 3 1 1 1 3 0 0 0 1 1 1 2 3 1 3 1 0 0 0 3 1 2 1 
i11017700 67 2 1 1 1 6 3 2 2 0 3 0 1 0 0 1 1 3 5 1 2 1 0 0 0 4 0 1 0 
i11017586 45 2 2 1 1 6 3 1 1 0 4 0 0 0 0 1 1 3 5 1 3 0 0 0 1 4 0 1 0 
i11017305 76 1 3 3 1 5 2 1 2 0 4 1 1 1 1 1 0 3 5 1 2 1 1 1 0 3 0 2 0 
i11016841 56 1 1 3 3 9 1 1 1 1 1 0 0 0 1 1 1 2 1 1 2 1 1 0 0 3 1 1 1 
i11016797 55 1 1 3 3 5 3 2 1 1 2 1 1 0 0 1 1 2 2 1 1 1 0 1 1 3 1 1 0 
i11016420 57 2 3 2 3 6 3 1 1 1 3 0 1 0 0 1 0 2 2 1 1 0 0 0 0 2 1 1 1 
i11016307 55 2 2 1 2 19 4 1 1 0 4 0 0 0 0 1 0 3 5 1 2 0 0 0 1 3 1 2 1 
i11006481 70 1 2 2 1 5 2 1 1 0 2 1 0 0 1 0 0 1 3 1 3 1 0 0 0 3 0 2 1 
Ip . no age sex ses yrs ulcer stay size depth na 
ture 
recur grade eye kidney bone pvd nerve sht Rx HE 
AL 
dis hba1c hosp sm 
oke 
alc 
ohol 
ampute site antibio cul 
ture 
mdro 
i11015847 65 1 1 2 1 10 3 1 2 1 3 1 0 1 1 1 1 4 6 1 3 1 1 0 1 6 1 2 1 
i11022480 50 1 2 2 4 14 4 1 2 0 4 0 1 0 1 1 1 3 5 1 2 0 1 0 0 4 1 2 1 
i11006024 55 1 3 2 1 25 3 1 2 0 5 0 0 0 1 1 0 4 6 1 3 0 0 0 0 3 0 2 1 
i11000493 45 1 2 1 1 2 3 2 2 0 5 0 0 0 0 1 0 3 5 1 3 1 1 0 0 2 1 1 0 
i11003875 66 2 3 2 1 5 2 1 1 0 2 0 0 0 0 1 1 1 2 1 2 1 0 1 0 1 0 1 0 
i11006760 63 1 4 2 2 7 2 1 2 1 3 0 0 1 1 1 0 2 3 1 2 0 1 0 0 5 0 2 1 
i11031011 63 2 3 1 3 20 3 1 2 0 3 0 1 0 1 1 0 2 3 1 3 0 0 0 0 4 0 1 1 
i11006024 55 1 3 4 1 25 3 1 2 1 5 1 1 1 1 1 0 4 6 1 3 0 1 1 1 6 0 2 1 
i11007987 65 1 4 3 2 10 3 1 1 1 3 0 0 0 1 1 0 2 2 1 2 0 0 0 0 3 0 1 1 
i11020303 58 1 3 4 1 60 4 1 2 1 5 1 0 1 1 1 0 4 6 1 3 0 1 0 1 6 0 2 1 
i11024587 64 1 2 3 1 7 2 1 2 1 5 1 0 1 0 1 0 4 6 1 3 0 0 1 0 6 0 2 1 
i11030786 53 1 2 1 2 3 1 1 1 0 1 0 0 0 0 0 1 1 1 1 1 1 1 0 0 1 0 1 0 
i11032172 81 1 3 4 3 7 2 1 2 1 4 0 1 1 1 1 0 3 5 1 2 0 0 0 0 1 1 2 1 
i11034824 54 1 1 2 1 4 1 1 2 0 4 1 0 1 1 1 0 3 5 1 3 0 1 0 0 1 0 2 1 
i11035695 64 2 3 1 1 25 4 1 2 1 3 0 0 0 1 1 0 2 3 1 3 0 0 0 0 6 1 2 1 
i11018186 65 1 1 2 4 7 3 1 1 0 2 0 0 0 0 0 1 1 1 1 2 1 0 0 0 2 0 2 0 
i11019213 45 1 4 1 2 6 2 1 1 0 1 0 0 0 0 0 1 1 1 1 1 0 0 0 0 1 0 1 0 
i11019046 33 1 3 2 1 8 3 2 2 1 4 0 1 0 1 1 0 2 3 1 3 0 1 0 0 4 1 2 1 
i11018282 63 1 2 1 1 3 3 1 2 1 3 0 0 1 1 1 0 3 5 1 2 0 1 1 0 2 0 2 1 
i12001780 34 1 2 3 1 6 3 1 1 0 2 0 0 0 0 1 0 2 2 1 3 0 0 1 0 2 1 1 1 
i12001726 67 2 4 1 1 6 3 1 1 0 1 0 0 0 0 0 1 1 1 1 1 0 0 0 0 3 0 2 0 
i11035695 67 2 3 2 3 23 4 2 1 1 2 0 1 0 0 1 0 3 5 1 3 1 0 0 0 4 0 2 1 
i11029803 67 1 2 3 1 16 3 1 2 1 5 1 0 1 1 1 1 4 6 1 3 1 1 1 1 3 1 2 1 
i11035303 34 1 2 2 1 28 3 1 2 1 4 1 0 0 1 1 1 4 6 1 2 1 1 0 1 6 1 2 1 
i11000153 45 2 3 1 1 29 3 1 1 0 3 0 0 0 1 0 0 3 5 1 1 1 0 0 0 3 0 2 1 
i11008790 51 1 2 1 1 9 2 2 2 0 4 0 1 0 1 1 1 4 6 1 3 1 1 1 0 5 0 1 1 
i11027474 65 1 2 2 1 10 3 1 2 0 5 0 1 0 1 1 0 4 6 1 3 1 1 0 0 6 1 2 1 
i11006760 63 1 3 1 1 7 2 2 2 0 2 0 0 0 0 0 1 1 2 1 1 0 0 0 0 3 0 2 0 
i11009665 64 2 3 2 1 4 3 1 1 1 3 0 0 0 1 1 0 1 3 1 3 1 0 0 1 2 0 2 1 
i11010406 50 1 2 1 2 3 2 2 1 0 2 0 0 0 0 0 1 1 2 1 1 0 1 0 0 1 0 1 0 
i11023590 49 2 1 1 1 41 2 1 2 1 3 0 1 1 0 1 1 2 3 1 2 1 0 0 0 3 0 2 1 
i11003319 59 1 2 2 1 43 3 1 2 1 3 0 0 0 1 1 1 2 3 1 3 1 1 0 0 4 0 2 1 
Ip . no age sex ses yrs ulcer stay size depth na 
ture 
recur grade eye kidney bone pvd nerve sht Rx HE 
AL 
dis hba1c hosp sm 
oke 
alc 
ohol 
ampute site antibio cul 
ture 
mdro 
i11013608 64 1 2 1 1 4 2 2 1 0 4 1 0 1 1 1 0 2 3 1 3 1 0 0 0 2 1 1 1 
i11033555 45 1 2 1 2 6 3 1 1 1 2 0 1 0 1 0 1 2 3 1 3 1 1 0 1 6 0 1 1 
i11008859 57 1 1 1 2 3 4 1 1 1 2 0 0 0 1 1 1 2 3 1 3 0 1 1 0 1 1 2 1 
i11019336 61 1 2 1 3 16 4 2 1 0 2 0 0 0 1 1 1 2 2 1 1 0 1 0 0 2 0 1 0 
i11006415 47 1 1 4 1 22 2 1 2 1 3 1 1 0 1 1 0 3 5 1 1 0 1 1 0 1 0 2 1 
i10052376 65 1 1 2 1 17 2 2 1 0 1 0 1 0 0 1 1 2 2 1 2 0 0 0 0 1 0 2 0 
i11001634 58 1 2 1 2 11 5 1 1 0 2 1 0 0 0 1 0 2 3 1 2 1 0 1 0 4 0 1 1 
i11006781 70 1 3 2 1 20 2 1 2 0 3 0 0 0 0 0 0 2 2 1 2 1 1 0 0 3 1 1 1 
i11013608 64 1 2 1 1 4 2 1 2 1 3 0 1 0 1 1 0 2 3 1 3 1 1 1 0 3 0 1 1 
i11018282 63 1 2 1 1 4 3 2 1 0 1 0 0 0 0 1 1 1 2 1 1 0 0 0 0 5 0 1 0 
i11021390 60 1 1 1 1 22 3 2 1 0 2 0 0 0 0 1 1 2 2 1 2 0 0 1 0 6 0 2 0 
i11021623 65 1 2 1 1 24 2 1 2 1 3 0 1 0 0 1 0 2 3 1 2 1 0 1 0 1 0 1 1 
i11032172 81 1 2 5 1 7 2 1 2 1 4 1 1 1 1 1 1 3 5 1 3 1 1 0 1 3 0 2 1 
i11032535 66 1 2 1 1 32 5 1 2 1 4 0 0 0 0 1 1 2 2 1 2 1 1 1 0 4 0 2 1 
i11033621 64 2 4 1 1 18 4 1 2 0 3 0 1 0 0 1 1 2 3 1 1 0 0 0 0 5 0 2 1 
i11035695 64 2 4 1 1 23 4 1 2 1 3 0 1 0 0 1 0 2 2 1 1 1 0 0 0 5 1 2 1 
i11003668 40 2 2 2 1 14 3 2 1 0 2 0 0 0 0 0 0 2 2 1 2 0 0 0 0 4 0 1 0 
i11007908 50 1 3 3 1 13 3 2 1 0 2 0 0 0 0 1 0 1 2 1 1 0 1 0 0 3 0 1 0 
i11015052 60 1 2 1 1 6 4 2 1 0 2 0 1 0 0 0 0 1 2 1 2 0 0 0 0 2 0 1 0 
i11015372 67 1 3 1 1 5 2 2 1 0 2 0 0 0 0 0 0 1 1 1 1 0 0 1 0 2 0 2 0 
i11016035 65 1 1 1 1 7 1 2 1 0 1 0 0 0 0 1 1 2 2 1 2 0 1 0 0 3 0 1 0 
i11017812 74 1 3 1 1 2 2 2 1 0 2 0 1 0 1 1 0 2 2 1 1 0 0 1 0 6 0 1 0 
i11020851 62 1 2 2 3 5 3 2 2 1 3 0 1 0 1 0 1 3 5 1 2 1 1 1 0 3 0 2 0 
i11021390 60 1 2 1 1 28 4 2 1 0 2 0 1 1 0 1 1 2 2 1 2 0 1 0 0 5 0 2 0 
i11025934 53 1 1 1 1 13 1 2 1 0 1 0 0 0 0 1 1 2 1 1 2 1 0 0 1 1 1 1 0 
i11031667 59 1 2 4 4 19 2 1 2 1 4 0 1 1 1 1 1 4 6 1 1 1 0 1 0 2 0 1 1 
i11032332 55 1 3 1 1 3 3 2 1 0 2 0 1 1 0 0 0 2 3 1 3 0 1 1 0 3 0 1 0 
i11033590 66 1 2 1 1 17 5 1 1 1 3 0 1 0 1 1 1 2 3 1 3 1 0 0 0 4 1 1 1 
i11006024 55 1 1 2 1 26 3 1 2 1 5 0 1 1 1 1 1 4 6 1 2 1 1 0 0 6 0 2 1 
i11023570 47 1 3 1 1 3 2 1 1 0 2 0 0 0 0 0 0 2 2 1 3 1 1 1 0 3 0 1 1 
i11032164 53 1 2 2 1 4 2 1 2 1 2 0 1 1 0 1 1 2 3 1 2 1 1 1 1 2 1 1 1 
i11034824 54 1 2 2 2 4 3 1 2 1 3 0 1 1 0 1 1 3 5 1 3 1 1 1 1 2 0 2 1 
Ip . no age sex ses yrs ulcer stay size depth na 
ture 
recur grade eye kidney bone pvd nerve sht Rx HE 
AL 
dis hba1c hosp sm 
oke 
alc 
ohol 
ampute site antibio cul 
ture 
mdro 
i11003875 66 2 1 2 2 4 1 1 1 0 1 0 0 0 0 1 1 1 1 1 2 0 0 0 0 1 0 2 0 
i11017472 58 1 2 1 4 8 2 2 1 1 2 0 1 0 0 0 0 2 4 1 3 1 0 0 0 3 1 2 1 
i11020851 62 1 1 2 3 6 3 1 1 0 2 0 1 0 1 1 1 3 5 1 2 0 0 0 0 3 0 2 0 
i12005945 55 1 2 1 1 22 3 2 2 1 3 0 1 0 0 1 1 2 3 1 3 1 0 0 0 4 1 2 1 
i12024495 57 1 3 1 1 10 4 2 2 1 3 1 1 1 1 1 1 2 3 1 3 1 0 1 0 3 1 2 1 
i12021336 60 2 1 4 1 12 2 2 1 0 1 0 1 0 0 0 1 2 1 1 3 0 0 0 0 1 0 1 0 
i12014431 61 1 3 3 2 26 2 2 1 1 3 1 0 1 0 1 1 3 5 1 2 0 1 1 1 2 1 2 1 
i12012359 53 2 3 1 2 11 4 1 1 0 2 0 0 0 0 1 0 1 1 1 1 0 0 0 0 4 0 1 0 
i12000503 70 2 2 5 1 8 3 2 2 0 4 1 1 1 0 1 0 3 5 1 2 1 0 0 0 2 1 1 0 
i12002049 45 1 3 2 1 5 2 1 1 0 2 0 1 0 0 0 1 3 5 1 1 0 1 1 0 3 0 1 0 
i12002262 64 1 1 1 1 8 3 2 2 1 3 0 0 0 1 1 1 2 2 1 2 1 1 0 1 2 1 1 1 
i12002372 52 1 2 2 1 7 1 2 1 0 3 0 1 1 1 1 1 3 5 1 3 1 1 1 1 2 1 2 1 
i12002494 52 2 1 2 1 30 2 1 1 0 2 1 1 0 1 1 0 1 2 1 2 1 0 0 1 3 1 1 0 
i12002563 56 2 1 2 1 24 4 2 2 1 3 0 1 0 0 1 1 3 5 1 3 1 0 0 0 4 1 2 1 
i12016234 62 2 1 3 1 9 2 2 2 0 4 0 1 1 0 1 1 3 5 1 3 0 0 0 0 3 0 2 1 
i12019933 58 1 2 1 2 7 2 2 2 1 4 0 1 0 1 1 1 3 5 1 3 0 0 0 0 4 0 2 1 
i12019108 61 1 2 3 2 10 3 2 1 0 1 1 1 0 0 1 0 1 1 1 2 0 1 0 0 3 0 2 0 
i12019933 58 1 3 1 1 16 3 2 2 1 4 0 1 1 1 1 1 3 5 1 3 1 1 1 1 2 1 2 1 
i12000124 65 1 2 2 1 14 2 2 1 0 3 0 1 0 0 1 1 2 3 1 3 0 1 1 0 5 0 2 1 
i12001174 52 1 1 3 1 10 3 2 1 1 3 0 1 0 0 0 0 2 2 1 3 1 1 1 1 5 1 1 1 
i12009073 73 1 1 3 2 5 2 2 2 1 4 1 0 1 1 1 1 3 5 1 3 1 1 1 0 3 1 2 1 
i12012893 51 2 3 2 2 8 3 2 2 0 4 0 0 1 0 1 0 3 5 1 3 1 0 0 1 4 1 2 1 
i12021402 65 2 2 1 1 22 2 2 1 0 3 0 0 0 0 0 0 2 2 1 2 0 0 0 0 5 0 1 1 
i12012893 51 2 2 2 1 9 3 2 2 0 4 0 0 0 0 1 1 3 5 1 3 0 0 0 0 4 1 2 1 
i12002563 56 2 3 1 1 4 2 1 1 1 2 0 0 0 0 0 0 2 1 1 2 0 0 0 0 5 0 2 0 
i12013972 54 2 2 1 1 8 3 2 1 0 3 0 1 0 0 1 1 2 2 1 2 0 0 0 0 5 0 1 0 
i12016234 62 2 3 2 1 16 4 1 1 0 3 0 1 1 0 1 1 3 5 1 3 1 0 0 0 4 1 2 1 
i12018932 34 1 2 2 1 8 3 1 1 0 2 0 0 0 1 0 0 3 5 1 2 0 1 1 0 4 0 2 0 
i12019108 61 1 2 3 2 4 2 1 1 0 2 1 1 0 0 1 1 3 5 1 3 0 1 1 0 4 0 2 0 
i12023468 48 1 2 3 1 8 3 1 1 0 2 0 1 0 0 0 1 1 1 1 1 0 1 1 0 4 0 2 0 
i12000995 60 1 3 1 1 15 5 2 2 0 4 0 1 1 0 1 1 1 3 1 3 0 1 0 0 4 1 1 1 
i12017012 66 2 2 3 1 12 4 2 2 1 4 0 1 1 0 1 1 3 5 1 3 1 0 0 0 4 1 1 1 
Ip . no age sex ses yrs ulcer stay size depth na 
ture 
recur grade eye kidney bone pvd nerve sht Rx HE 
AL 
dis hba1c hosp sm 
oke 
alc 
ohol 
ampute site antibio cul 
ture 
mdro 
i12014705 58 1 2 2 1 5 3 1 1 1 2 0 0 0 1 1 1 2 3 1 3 0 1 1 0 4 0 1 0 
i12002262 64 1 2 3 2 8 2 1 1 0 1 0 1 0 0 1 1 1 2 1 3 0 1 1 0 5 0 1 0 
i12012893 51 2 2 3 1 15 3 2 2 1 4 1 1 1 0 1 0 3 5 1 3 1 0 0 0 4 1 2 1 
i11034824 54 1 3 2 1 32 4 2 2 1 4 0 1 1 1 1 1 3 5 1 3 1 0 1 1 3 1 2 1 
i12020408 61 1 2 3 1 12 3 2 1 1 2 0 0 1 0 1 1 1 2 1 2 1 1 1 1 2 1 2 1 
i12007346 55 1 1 3 1 17 4 2 2 1 5 1 1 1 1 1 1 4 6 1 3 1 1 1 0 6 1 1 1 
i12012152 55 2 1 4 2 28 3 2 1 0 4 0 0 1 0 1 0 3 5 1 3 1 0 0 1 4 1 2 1 
i11034824 54 1 2 2 1 40 3 1 2 1 3 0 0 0 0 0 1 2 2 1 2 1 0 0 1 5 1 2 1 
i11036295 65 2 1 1 1 30 2 2 2 0 4 0 1 0 0 1 1 2 2 1 2 0 0 0 0 3 0 2 1 
i12001458 66 1 1 4 2 12 3 1 2 0 4 0 1 0 0 1 1 3 5 1 1 1 1 1 0 3 0 2 1 
i12005065 47 1 2 2 2 5 2 1 1 1 2 0 1 0 1 1 1 1 2 1 2 1 1 1 1 2 1 1 0 
i12009073 73 1 1 1 2 13 3 2 2 1 4 1 1 0 1 1 1 1 2 1 3 0 1 1 0 3 0 2 1 
i12012153 64 1 1 4 2 13 2 1 1 1 2 1 1 1 0 1 1 1 2 1 2 1 0 1 1 3 1 2 1 
i12014431 61 1 2 2 1 26 3 1 2 0 3 1 1 1 0 1 1 2 2 1 1 1 0 1 0 4 1 2 1 
i21015232 49 1 1 2 2 3 2 1 1 0 1 0 0 0 0 0 0 1 2 1 3 0 1 1 0 4 0 1 0 
i12000995 60 1 1 2 1 6 3 1 2 1 3 0 1 1 1 1 1 2 3 1 2 1 1 1 0 3 1 1 1 
i12002823 64 1 2 2 1 8 3 2 2 1 4 1 1 0 0 1 1 3 5 1 3 1 0 0 1 4 1 1 1 
i12003160 35 1 1 1 1 9 3 1 1 0 3 0 0 0 1 0 1 2 3 1 3 0 1 0 0 6 0 2 1 
i12006343 61 1 3 1 1 21 2 1 1 1 3 1 1 0 1 0 1 2 2 1 1 0 1 1 0 3 1 2 1 
i12009179 63 1 2 2 1 14 1 1 1 0 1 0 0 0 0 0 0 1 1 1 1 1 0 0 0 3 0 1 0 
i12005018 63 1 2 1 2 23 2 2 2 0 4 1 1 1 1 1 1 3 5 1 3 0 1 1 0 4 0 2 1 
i12006648 53 1 1 1 1 8 4 1 2 1 3 1 0 1 0 1 1 2 3 1 2 0 1 0 0 4 0 2 1 
i12008244 75 1 2 4 1 4 1 2 2 1 3 0 0 1 1 1 1 2 3 1 2 0 0 1 0 2 0 1 1 
i12011769 59 1 1 4 1 13 3 2 1 1 4 1 1 1 1 1 1 3 5 1 3 0 1 1 1 5 1 1 1 
 
